@NP	Increased Expression	1
@NP	Cyclo-Oxygenase 2 and Vascular Endothelial Growth Factor in Lesioned Spinal Cord	25
@NP	Cyclo-Oxygenase 2	25
@NP	Vascular Endothelial Growth Factor in Lesioned Spinal Cord	47
@NP	Vascular Endothelial Growth Factor	47
@NP	Lesioned Spinal Cord	85
@NP	Olfactory Ensheathing Cells	122
@NP	LÓPEZ-VALES ,1 GUILLERMO GARCÍA-ALÍAS	157
@NP	,1 JOAQUIM FORÉS ,1,2 XAVIER NAVARRO ,1	193
@NP	,1 JOAQUIM FORÉS	193
@NP	,1,2 XAVIER NAVARRO ,1	209
@NP	ENRIQUE VERDÚ1 ABSTRACT Olfactory ensheathing cells -LRB- OECs -RRB-	235
@NP	ENRIQUE VERDÚ1 ABSTRACT	235
@NP	Olfactory ensheathing cells -LRB- OECs -RRB-	260
@NP	Olfactory ensheathing cells	260
@NP	OECs	289
@NP	adult rats	316
@NP	photochemical injury of the spinal cord	333
@NP	photochemical injury	333
@NP	the spinal cord	357
@NP	Rats	374
@NP	180,000 OECs suspended in DMEM or DMEM alone	395
@NP	180,000 OECs	395
@NP	DMEM or DMEM	421
@NP	Locomotor ability	441
@NP	the BBB-scale , pain sensibility , and motor and somatosensory	469
@NP	the BBB-scale	469
@NP	pain sensibility	484
@NP	motor and somatosensory	506
@NP	potentials	537
@NP	the first 14 days	570
@NP	3 , 7 , and 14 days	605
@NP	3	605
@NP	7	608
@NP	14 days	615
@NP	5 rats per day of both groups	624
@NP	5 rats	624
@NP	day of both groups	635
@NP	day	635
@NP	both groups	642
@NP	transverse sections from proximal , lesioned and distal spinal cord blocks	672
@NP	transverse sections	672
@NP	proximal , lesioned and distal spinal cord blocks	697
@NP	COX-2 , VEGF , GFAP and lectin	763
@NP	The BBB-score and the amplitude of motor and somatosensory	793
@NP	The BBB-score	793
@NP	the amplitude of motor and somatosensory	811
@NP	the amplitude	811
@NP	motor and somatosensory	828
@NP	potentials	859
@NP	OEC	899
@NP	DMEM-injected animals throughout follow-up	912
@NP	DMEM-injected animals	912
@NP	follow-up	945
@NP	the withdrawal latency to heat noxious stimulus	964
@NP	the withdrawal latency	964
@NP	heat noxious stimulus	990
@NP	OEC	1025
@NP	DMEM-injected rats	1038
@NP	The area of preserved spinal cord and the levels of COX-2 and VEGF staining	1058
@NP	The area of preserved spinal cord	1058
@NP	The area	1058
@NP	preserved spinal cord	1070
@NP	the levels of COX-2 and VEGF staining	1096
@NP	the levels	1096
@NP	COX-2 and VEGF staining	1110
@NP	OEC	1163
@NP	DMEM-injected rats	1176
@NP	GFAP	1196
@NP	no LEC-positive cells	1206
@NP	COX-2 staining	1238
@NP	OEC-transplanted rats	1256
@NP	The density of blood vessels	1279
@NP	The density	1279
@NP	blood vessels	1294
@NP	OEC	1344
@NP	respect	1354
@NP	DMEM-injected rats	1365
@NP	Our results	1385
@NP	OECs	1407
@NP	functional and morphological preservation of the spinal cord	1420
@NP	functional and morphological preservation	1420
@NP	the spinal cord	1465
@NP	photochemical injury	1487
@NP	increasing neoangiogenesis	1509
@NP	up-regulation of COX-2 and VEGF expression in astrocytes	1540
@NP	up-regulation	1540
@NP	COX-2 and VEGF expression in astrocytes	1557
@NP	COX-2 and VEGF expression	1557
@NP	astrocytes	1586
@NP	INTRODUCTION ENDOTHELIAL DAMAGE	1599
@NP	INTRODUCTION	1599
@NP	ENDOTHELIAL DAMAGE	1612
@NP	release of inflammatory mediators	1632
@NP	release	1632
@NP	inflammatory mediators	1643
@NP	changes in vascular permeability	1667
@NP	changes	1667
@NP	vascular permeability	1678
@NP	edema , infiltration of inflammatory cells	1701
@NP	edema	1701
@NP	infiltration of inflammatory cells	1708
@NP	infiltration	1708
@NP	inflammatory cells	1724
@NP	activation of astrocytes and microglia	1748
@NP	activation	1748
@NP	astrocytes and microglia	1762
@NP	pathophysiological findings	1791
@NP	spinal cord injury -LRB- Schwab and Bartholdi , 1996 -RRB-	1834
@NP	spinal cord injury	1834
@NP	Schwab and Bartholdi	1854
@NP	1996	1876
@NP	Experimental evidence	1883
@NP	these responses	1919
@NP	they	2011
@NP	Schwartz , 2000 ; Bethea and Dietrich , 2002	2071
@NP	Schwartz	2071
@NP	2000 ; Bethea and Dietrich	2081
@NP	2000	2081
@NP	Bethea and Dietrich	2087
@NP	2002	2108
@NP	complete transection of spinal cord	2121
@NP	complete transection	2121
@NP	spinal cord	2145
@NP	local administration of pre-activated macrophages	2158
@NP	local administration	2158
@NP	pre-activated macrophages	2182
@NP	axonal regrowth -LRB- Rapalino et al. , 1998 -RRB-	2217
@NP	axonal regrowth	2217
@NP	Rapalino	2234
@NP	et al. , 1998	2243
@NP	et al.	2243
@NP	1998	2251
@NP	Cytokines and growth factors	2258
@NP	macrophages	2299
@NP	activated microglia and astrocytes	2324
@NP	this effect -LRB- Rapalino et al. , 1998 -RRB-	2371
@NP	this effect	2371
@NP	Rapalino	2384
@NP	et al. , 1998	2393
@NP	et al.	2393
@NP	1998	2401
@NP	the context of spinal cord trauma	2411
@NP	the context	2411
@NP	spinal cord trauma	2426
@NP	it	2446
@NP	a matter of controversy	2458
@NP	a matter	2458
@NP	controversy	2470
@NP	cytokines	2490
@NP	a beneficial or a detrimental effect	2505
@NP	the injured tissue -LRB- Hirschberg et al. , 1994 ; Bethea et al. , 1999 -RRB-	2545
@NP	the injured tissue	2545
@NP	Hirschberg	2565
@NP	et al. , 1994 ; Bethea et al. , 1999	2576
@NP	et al.	2576
@NP	1994 ; Bethea et al.	2584
@NP	1994	2584
@NP	Bethea et al.	2590
@NP	Bethea	2590
@NP	et al.	2597
@NP	1999	2605
@NP	Cytokines and other factors	2612
@NP	Cytokines	2612
@NP	other factors	2626
@NP	distinctive and possible opposing effects	2650
@NP	the phase of recovery	2706
@NP	the phase	2706
@NP	recovery	2719
@NP	rescue or regrowth	2743
@NP	Schwartz et al. , 1996 ; Schwartz , 2000	2789
@NP	Schwartz	2789
@NP	et al. , 1996 ; Schwartz , 2000	2798
@NP	et al. , 1996	2798
@NP	et al.	2798
@NP	1996	2806
@NP	Schwartz , 2000	2812
@NP	Schwartz	2812
@NP	2000	2822
@NP	Activation	2829
@NP	cyclo-oxygenase -LRB- COX -RRB-	2843
@NP	cyclo-oxygenase	2843
@NP	COX	2860
@NP	inducible nitric oxide synthase -LRB- iNOS -RRB-	2866
@NP	inducible nitric oxide synthase	2866
@NP	iNOS	2899
@NP	their products	2909
@NP	the lesion site	2933
@NP	the acute phase -LRB- Schwab and Bartholdi , 1996 -RRB-	2956
@NP	the acute phase	2956
@NP	Schwab and Bartholdi	2973
@NP	1996	2995
@NP	COX-2 mRNA	3002
@NP	mechanical injury	3029
@NP	the spinal cord -LRB- Resnick et al. , 1998 ; Tonai et al. , 1999 -RRB-	3050
@NP	the spinal cord	3050
@NP	Resnick	3067
@NP	et al. , 1998 ; Tonai et al. , 1999	3075
@NP	et al.	3075
@NP	1998 ; Tonai et al.	3083
@NP	1998	3083
@NP	Tonai et al.	3089
@NP	Tonai	3089
@NP	et al.	3095
@NP	1999	3103
@NP	intraspinal injection of interleukin-1 -LRB- Tonai et al. , 1999 -RRB-	3120
@NP	intraspinal injection	3120
@NP	interleukin-1 -LRB- Tonai et al. , 1999 -RRB-	3145
@NP	interleukin-1	3145
@NP	Tonai	3160
@NP	et al. , 1999	3166
@NP	et al.	3166
@NP	1999	3174
@NP	COX-2 expression	3181
@NP	hypoxia , peroxidation and excitatory amino acid	3217
@NP	neuronal death	3273
@NP	spinal cord injury -LRB- Siesjo , 1992 -RRB-	3294
@NP	spinal cord injury	3294
@NP	Siesjo	3314
@NP	1992	3322
@NP	Sköld et al. -LRB- 2000 -RRB-	3339
@NP	Sköld et al.	3339
@NP	Sköld	3339
@NP	et al.	3345
@NP	2000	3353
@NP	vascular endothelial growth factor -LRB- VEGF -RRB- and its receptors	3373
@NP	vascular endothelial growth factor -LRB- VEGF -RRB-	3373
@NP	vascular endothelial growth factor	3373
@NP	VEGF	3409
@NP	its receptors	3419
@NP	mechanical spinal cord injury	3451
@NP	Intraspinal injections of PGF2alpha	3482
@NP	Intraspinal injections	3482
@NP	PGF2alpha	3508
@NP	the expression of VEGF mRNA and protein	3538
@NP	the expression	3538
@NP	VEGF mRNA and protein	3556
@NP	the injection area -LRB- Sköld et al. , 2000 -RRB-	3581
@NP	the injection area	3581
@NP	Sköld	3601
@NP	et al. , 2000	3607
@NP	et al.	3607
@NP	2000	3615
@NP	These findings	3622
@NP	prostaglandins , a product of the COX-2 pathway ,	3650
@NP	prostaglandins	3650
@NP	a product of the COX-2 pathway	3666
@NP	a product	3666
@NP	the COX-2 pathway	3679
@NP	the expression	3707
@NP	VEGF	3725
@NP	a growth factor	3731
@NP	endothelial cell proliferation , angiogenesis and vascular permeability	3759
@NP	Proescholdt	3831
@NP	et al. , 1999	3843
@NP	et al.	3843
@NP	1999	3851
@NP	We	3858
@NP	transplants of olfactory ensheathing glia cells -LRB- OECs -RRB-	3886
@NP	transplants	3886
@NP	olfactory ensheathing glia cells -LRB- OECs -RRB-	3901
@NP	olfactory ensheathing glia cells	3901
@NP	OECs	3935
@NP	spinal cord parenchyma preservation	3964
@NP	photochemical spinal cord injury -LRB- Verdú et al. , 2001 , 2003a -RRB-	4006
@NP	photochemical spinal cord injury	4006
@NP	Verdú	4040
@NP	et al. , 2001 , 2003a	4046
@NP	et al.	4046
@NP	2001	4054
@NP	2003a	4060
@NP	the mechanisms implicated in this neuroprotective role	4077
@NP	the mechanisms	4077
@NP	this neuroprotective role	4106
@NP	This report	4151
@NP	OEC transplants	4199
@NP	the immune and inflammatory responses	4235
@NP	spinal cord injury	4279
@NP	We	4299
@NP	OECs transplants	4320
@NP	the expression of COX-2 and VEGF	4348
@NP	the expression	4348
@NP	COX-2 and VEGF	4366
@NP	neoangiogenesis in the injured spinal cord parenchyma	4394
@NP	neoangiogenesis	4394
@NP	the injured spinal cord parenchyma	4413
@NP	the first days postlesion	4455
@NP	MATERIALS AND METHODS	4483
@NP	MATERIALS	4483
@NP	METHODS	4497
@NP	Primary Cultures of OECs , Immunopurification , and Cryopreservation OECs	4505
@NP	Primary Cultures	4505
@NP	OECs , Immunopurification , and Cryopreservation OECs	4525
@NP	primary cultures of olfactory bulbs	4596
@NP	primary cultures	4596
@NP	olfactory bulbs	4616
@NP	adult -LRB- 2.5 -- 3.0 months old -RRB- female Sprague-Dawley rats	4638
@NP	2.5 -- 3.0 months old	4645
@NP	2.5	4645
@NP	3.0 months old	4649
@NP	the method described by Gudiño-Cabrera and Nieto-Sampedro	4699
@NP	the method	4699
@NP	Gudiño-Cabrera and Nieto-Sampedro	4723
@NP	1996	4758
@NP	2000	4764
@NP	minor modifications -LRB- Verdú et al. , 2003a -RRB-	4775
@NP	minor modifications	4775
@NP	Verdú	4796
@NP	et al. , 2003a	4802
@NP	et al.	4802
@NP	2003a	4810
@NP	the bulbs	4827
@NP	Hank 's balanced salt solution -LRB- HBSS , H-6136 , Sigma , St Louis , MO -RRB-	4876
@NP	Hank 's balanced salt solution	4876
@NP	Hank 's	4876
@NP	HBSS , H-6136 , Sigma , St Louis , MO	4907
@NP	HBSS	4907
@NP	H-6136	4913
@NP	Sigma	4921
@NP	St Louis	4928
@NP	MO	4938
@NP	calcium and magnesium	4947
@NP	0 °C	4972
@NP	The meningeal layer	4977
@NP	fine forceps	5019
@NP	the bulbs	5037
@NP	0.25 % trypsin -LRB- GIBCO , Life Technologies , Paisley , Scotland -RRB-	5065
@NP	0.25 % trypsin	5065
@NP	GIBCO	5080
@NP	Life Technologies	5087
@NP	Paisley , Scotland	5106
@NP	0.1 % collagenase A -LRB- GIBCO , Life Technologies -RRB-	5126
@NP	0.1 % collagenase A	5126
@NP	GIBCO	5146
@NP	Life Technologies	5153
@NP	0.1 % DNAse-I -LRB- Boehringer Mannheim , Germany -RRB-	5176
@NP	0.1 % DNAse-I	5176
@NP	Boehringer Mannheim	5190
@NP	Germany	5211
@NP	1 mL of HBSS	5223
@NP	1 mL	5223
@NP	HBSS	5231
@NP	calcium and magnesium -LRB- H-2387 , Sigma -RRB- at 37 °C for 45 -- 60 min	5244
@NP	calcium and magnesium -LRB- H-2387 , Sigma -RRB- at 37 °C for 45	5244
@NP	calcium and magnesium -LRB- H-2387 , Sigma -RRB-	5244
@NP	calcium and magnesium	5244
@NP	H-2387	5267
@NP	Sigma	5275
@NP	37 °C for 45	5285
@NP	37 °C	5285
@NP	45	5294
@NP	60 min	5297
@NP	incubation	5311
@NP	tissue	5323
@NP	a flame-constricted Pasteur pipette	5365
@NP	enzymes	5405
@NP	the addition	5433
@NP	10 mL	5449
@NP	Dulbecco 's minimum essential medium nutrient mixture F-12 Ham	5458
@NP	Dulbecco 's	5458
@NP	DMEM	5521
@NP	D-8900	5527
@NP	Sigma	5535
@NP	10 % fetal calf serum	5547
@NP	FCS	5569
@NP	Biological Industries	5574
@NP	Israel	5597
@NP	The cell mixture	5606
@NP	centrifugation	5640
@NP	900 rpm for 7 min	5658
@NP	900 rpm	5658
@NP	7 min	5670
@NP	culture medium	5695
@NP	Cells	5711
@NP	25 cm2 flasks	5739
@NP	poly-Llysine -LRB- 10 µg/mL , P-7890 , Sigma -RRB-	5765
@NP	poly-Llysine	5765
@NP	10 µg/mL	5779
@NP	P-7890	5789
@NP	Sigma	5797
@NP	5 % CO2 at 37 °C	5822
@NP	5 % CO2	5822
@NP	37 °C	5832
@NP	Culture medium	5838
@NP	DMEM with 10 % FCS	5857
@NP	DMEM	5857
@NP	10 % FCS	5867
@NP	9 days in vitro	5879
@NP	9 days	5879
@NP	this medium	5896
@NP	a defined medium	5924
@NP	OECs -LRB- Gudiño-Cabrera and Nieto-Sampedro , 2000 -RRB-	5955
@NP	OECs	5955
@NP	Gudiño-Cabrera and Nieto-Sampedro , 2000	5961
@NP	Gudiño-Cabrera and Nieto-Sampedro	5961
@NP	2000	5996
@NP	confluence -LRB- 12 -- 15 days in vitro -RRB-	6018
@NP	confluence	6018
@NP	12	6030
@NP	15 days in vitro	6033
@NP	15 days	6033
@NP	vitro	6044
@NP	OECs	6052
@NP	incubation	6074
@NP	trypsin-EDTA -LRB- T - 3924 , Sigma -RRB-	6090
@NP	trypsin-EDTA	6090
@NP	T	6104
@NP	3924 , Sigma	6107
@NP	3924	6107
@NP	Sigma	6113
@NP	Trypsin action	6121
@NP	addition of medium	6152
@NP	addition	6152
@NP	medium	6164
@NP	the cell mixture	6175
@NP	centrifugation	6209
@NP	900 rpm for 7 min	6227
@NP	900 rpm	6227
@NP	7 min	6239
@NP	OECs	6246
@NP	mean of magnetic Dynabeads M-450 -LRB- DBM-450 , Dynal , Oslo , Norway -RRB-	6274
@NP	mean of magnetic Dynabeads M-450	6274
@NP	mean	6274
@NP	magnetic Dynabeads	6282
@NP	DBM-450	6308
@NP	Dynal	6317
@NP	Oslo , Norway	6324
@NP	goat anti-mouse IgG	6354
@NP	mouse	6392
@NP	monoclonal 192 IgG antibodies	6398
@NP	192	6409
@NP	MAB365	6429
@NP	Chemicon	6437
@NP	Temecula , CA	6447
@NP	the p75-NGF receptor -LRB- Gudiño-Cabrera and Nieto - Sampedro , 1996 -RRB-	6476
@NP	the p75-NGF receptor	6476
@NP	Gudiño-Cabrera and Nieto - Sampedro , 1996	6498
@NP	Gudiño-Cabrera and Nieto - Sampedro	6498
@NP	Gudiño-Cabrera and Nieto	6498
@NP	Gudiño-Cabrera	6498
@NP	Nieto	6517
@NP	Sampedro	6524
@NP	1996	6534
@NP	the p75-positive cells	6550
@NP	freezing medium -LRB- C-6295 , Sigma -RRB-	6593
@NP	freezing medium	6593
@NP	C-6295	6610
@NP	Sigma	6618
@NP	4 °C , transferred to -20 °C for 10 min , then to a deep freezer at -80 °C	6639
@NP	4 °C	6639
@NP	-20 °C for 10 min	6659
@NP	-20 °C	6659
@NP	10 min	6669
@NP	a deep freezer at -80 °C	6685
@NP	a deep freezer	6685
@NP	-80 °C	6703
@NP	transplantation	6714
@NP	frozen cell vials	6731
@NP	37 °C	6764
@NP	two times	6777
@NP	centrifugation	6790
@NP	900 rpm , 7 min	6806
@NP	900 rpm	6806
@NP	7 min	6815
@NP	DMEM	6825
@NP	the pellet resuspended in the same medium	6835
@NP	the pellet	6835
@NP	the same medium	6861
@NP	The cells	6878
@NP	2 h of thawing	6913
@NP	2 h	6913
@NP	thawing	6920
@NP	our culture conditions	6935
@NP	more than 90 % of cells in primary cultures	6959
@NP	more than 90 %	6959
@NP	cells in primary cultures	6976
@NP	cells	6976
@NP	primary cultures	6985
@NP	spindle-like morphology	7007
@NP	two or three processes	7036
@NP	less than 10 % of cells	7066
@NP	less than 10 %	7066
@NP	cells	7083
@NP	a flattened appearance	7093
@NP	A few macrophages/microglial cells	7117
@NP	the cultures	7176
@NP	accordance	7193
@NP	previous studies -LRB- Gudiño-Cabrera and Nieto - Sampedro , 1996 -RRB-	7209
@NP	previous studies	7209
@NP	Gudiño-Cabrera and Nieto - Sampedro , 1996	7227
@NP	Gudiño-Cabrera and Nieto - Sampedro	7227
@NP	Gudiño-Cabrera and Nieto	7227
@NP	Gudiño-Cabrera	7227
@NP	Nieto	7246
@NP	Sampedro	7253
@NP	1996	7263
@NP	more than 97 % of the immunopurified cells	7270
@NP	more than 97 %	7270
@NP	the immunopurified cells	7287
@NP	the majority of transplanted OECs	7345
@NP	the majority	7345
@NP	transplanted OECs	7361
@NP	spindle-shaped p75-positive cells	7383
@NP	Schwann-cell	7431
@NP	phenotype	7449
@NP	Gudiño	7460
@NP	Cabrera and Nieto-Sampedro	7468
@NP	1996 , 2000 ; Franceschini and Barnett , 1996 ; Wewetzer et al.	7496
@NP	1996 , 2000	7496
@NP	1996	7496
@NP	2000	7502
@NP	Franceschini and Barnett , 1996	7508
@NP	Franceschini and Barnett	7508
@NP	1996	7534
@NP	Wewetzer et al.	7540
@NP	Wewetzer	7540
@NP	et al.	7549
@NP	2000	7557
@NP	Trypan blue	7564
@NP	the viable cell number	7607
@NP	unstained cells	7643
@NP	a haemocytometer	7677
@NP	the percentage of cell viability	7698
@NP	the percentage	7698
@NP	cell viability	7716
@NP	The trypan blue	7747
@NP	test	7769
@NP	three times	7787
@NP	Our counts	7800
@NP	the percentage of thawed viable cells	7823
@NP	the percentage	7823
@NP	thawed viable cells	7841
@NP	97 -- 98 % from the total cells	7871
@NP	97	7871
@NP	98 % from the total cells	7874
@NP	98 %	7874
@NP	the total cells	7883
@NP	Spinal Cord Injury and OEC	7900
@NP	Spinal Cord Injury	7900
@NP	OEC	7923
@NP	Thirty adult female Sprague-Dawley rats -LRB- 250 -- 300 g -RRB-	7943
@NP	Thirty adult female Sprague-Dawley rats	7943
@NP	250 -- 300 g	7984
@NP	250	7984
@NP	300 g	7988
@NP	sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	8018
@NP	sodium pentobarbital	8018
@NP	50 mg/kg , i.p.	8040
@NP	50 mg/kg	8040
@NP	a heating pad	8076
@NP	body temperature constant	8102
@NP	The back of the animals	8129
@NP	The back	8129
@NP	the animals	8141
@NP	povidone iodine	8185
@NP	a longitudinal incision from mid to low thoracic vertebrae	8206
@NP	a longitudinal incision	8206
@NP	mid to low thoracic vertebrae	8235
@NP	The spinal cord	8275
@NP	a dorsal laminectomy of T8 vertebra	8306
@NP	a dorsal laminectomy	8306
@NP	T8 vertebra	8330
@NP	The dura	8343
@NP	penetration of solutions	8384
@NP	penetration	8384
@NP	solutions	8399
@NP	Rose Bengal -LRB- RB ; 1.5 % in saline , Sigma -RRB-	8410
@NP	Rose Bengal	8410
@NP	RB ; 1.5 % in saline , Sigma	8423
@NP	RB	8423
@NP	1.5 % in saline , Sigma	8427
@NP	1.5 %	8427
@NP	saline , Sigma	8435
@NP	saline	8435
@NP	Sigma	8443
@NP	the exposed spinal cord for 10 minutes	8474
@NP	the exposed spinal cord	8474
@NP	10 minutes	8502
@NP	this time	8521
@NP	the dye easily	8532
@NP	the	8532
@NP	the cord parenchyma	8558
@NP	the gray matter -LRB- Verdú et al. , 2003b -RRB-	8604
@NP	the gray matter	8604
@NP	Verdú	8621
@NP	et al. , 2003b	8627
@NP	et al.	8627
@NP	2003b	8635
@NP	the excess	8649
@NP	a double saline rinse	8679
@NP	The lesion	8702
@NP	the exposed dorsal surface of the spinal cord by means of a 5-mm diameter	8741
@NP	the exposed dorsal surface	8741
@NP	the spinal cord by means of a 5-mm diameter	8771
@NP	the spinal cord	8771
@NP	means of a 5-mm diameter	8790
@NP	means	8790
@NP	a 5-mm diameter	8799
@NP	optic fiber	8815
@NP	10 mm	8838
@NP	top of the cord -LRB- Verdú et al. , 2003a , b -RRB-	8847
@NP	top	8847
@NP	the cord -LRB- Verdú et al. , 2003a , b -RRB-	8854
@NP	the cord	8854
@NP	Verdú	8864
@NP	et al. , 2003a , b	8870
@NP	et al.	8870
@NP	2003a	8878
@NP	b	8884
@NP	The optic fiber	8888
@NP	a halogen lamp equipped with a 100 -- W Xenophot halogen bulb	8921
@NP	a halogen lamp	8921
@NP	a 100 -- W Xenophot halogen bulb	8950
@NP	a 100	8950
@NP	W Xenophot halogen bulb	8956
@NP	W Xenophot	8956
@NP	halogen bulb	8967
@NP	reproducible light intensity	8991
@NP	the irradiation power at the fiber outlet	9021
@NP	the irradiation power	9021
@NP	the fiber outlet	9046
@NP	means of a digital lux tester	9079
@NP	means	9079
@NP	a digital lux tester	9088
@NP	Spinal cord	9110
@NP	a light intensity of 200 kLux	9141
@NP	a light intensity	9141
@NP	200 kLux	9162
@NP	2.5 min	9178
@NP	damage	9198
@NP	the calorific source of the halogen lamp	9208
@NP	the calorific source	9208
@NP	the halogen lamp	9232
@NP	the illumination time	9257
@NP	the spinal cord	9279
@NP	saline solution	9311
@NP	this spinal cord injury	9353
@NP	cytotoxic edema	9384
@NP	astrocytic swelling	9405
@NP	red blood cell extravasation and myelin degradation	9426
@NP	Verdú	9479
@NP	et al. , 2003b	9485
@NP	et al.	9485
@NP	2003b	9493
@NP	Thirty minutes	9501
@NP	injury	9522
@NP	15 animals	9530
@NP	four injections of a suspension of OECs -LRB- 45000 in 3 µL of DMEM each -RRB-	9550
@NP	four injections	9550
@NP	a suspension of OECs -LRB- 45000 in 3 µL of DMEM each -RRB-	9569
@NP	a suspension	9569
@NP	OECs -LRB- 45000 in 3 µL of DMEM each -RRB-	9585
@NP	OECs	9585
@NP	45000 in 3 µL of DMEM each	9591
@NP	45000	9591
@NP	3 µL of DMEM each	9600
@NP	3 µL	9600
@NP	DMEM each	9608
@NP	DMEM	9608
@NP	each	9613
@NP	the exposed spinal cord -LRB- group OEC -RRB-	9624
@NP	the exposed spinal cord	9624
@NP	group OEC	9649
@NP	Two injections	9661
@NP	1 mm rostral and two injections 1 mm caudal	9689
@NP	1 mm rostral	9689
@NP	two injections 1 mm caudal	9706
@NP	two injections	9706
@NP	1 mm caudal	9721
@NP	the lesion epicenter , and one injection	9736
@NP	the lesion epicenter	9736
@NP	one injection	9762
@NP	each side 0.5 mm lateral to the cord midline	9779
@NP	each side 0.5 mm lateral	9779
@NP	the cord midline	9807
@NP	The glass micropipette	9825
@NP	the dorsal surface	9876
@NP	1 mm	9895
@NP	the spinal cord	9910
@NP	Each animal	9927
@NP	a total of 180,000 OECs	9948
@NP	a total	9948
@NP	180,000 OECs	9959
@NP	Another 15 rats	9973
@NP	four injections of an equal volume of vehicle alone -LRB- group DMEM -RRB-	9998
@NP	four injections	9998
@NP	an equal volume of vehicle alone -LRB- group DMEM -RRB-	10017
@NP	an equal volume	10017
@NP	vehicle alone -LRB- group DMEM -RRB-	10036
@NP	vehicle alone	10036
@NP	group DMEM	10051
@NP	The suspension	10064
@NP	a glass micropipette	10099
@NP	means	10123
@NP	20 msec pulses	10141
@NP	10 psi	10159
@NP	Picospitzer II , General Valve , Fairfield , NJ ; Verdú et al. , 2001 , 2003a	10167
@NP	Picospitzer II , General Valve	10167
@NP	Picospitzer II	10167
@NP	General Valve	10183
@NP	Fairfield , NJ ; Verdú et al.	10198
@NP	Fairfield , NJ	10198
@NP	Verdú et al.	10213
@NP	Verdú	10213
@NP	et al.	10219
@NP	2001 , 2003a	10227
@NP	2001	10227
@NP	2003a	10233
@NP	the wound	10250
@NP	the animals	10275
@NP	a warm environment	10300
@NP	full recovery	10325
@NP	Functional Evaluation Functional tests	10340
@NP	operation	10401
@NP	3 , 7 , and 14 days postoperation -LRB- dpo -RRB-	10418
@NP	3	10418
@NP	7	10421
@NP	14 days postoperation -LRB- dpo -RRB-	10428
@NP	14 days	10428
@NP	postoperation -LRB- dpo -RRB-	10436
@NP	postoperation	10436
@NP	dpo	10451
@NP	Locomotor activity	10457
@NP	the open-field walking scoring system	10496
@NP	the locomotor ability	10548
@NP	5 min	10577
@NP	One animal at a time	10584
@NP	One animal	10584
@NP	a time	10598
@NP	a circular plastic tray -LRB- 90 cm diameter 24 cm wall height -RRB-	10639
@NP	a circular plastic tray	10639
@NP	90 cm diameter 24 cm wall height	10664
@NP	90 cm diameter	10664
@NP	24 cm wall height	10681
@NP	Two independent examiners	10701
@NP	the hind-limb movements of the rat	10736
@NP	the hind-limb movements	10736
@NP	the rat	10763
@NP	the locomotor function	10783
@NP	the Basso , Beattie and Bresnahan scale	10819
@NP	Basso , Beattie and Bresnahan	10823
@NP	BBB scale	10859
@NP	Basso et al. , 1995	10870
@NP	Basso	10870
@NP	et al.	10876
@NP	1995	10884
@NP	The final score of each animal	10891
@NP	The final score	10891
@NP	each animal	10910
@NP	the mean value of both examiners	10926
@NP	the mean value	10926
@NP	examiners	10949
@NP	The BBB scale	10960
@NP	0 -LRB- no hindlimb movement -RRB-	10986
@NP	0	10986
@NP	no hindlimb movement	10989
@NP	21 -LRB- normal movement-coordinated gait -RRB-	11014
@NP	21	11014
@NP	normal movement-coordinated gait	11018
@NP	Animals	11053
@NP	the inclined plane test -LRB- Rivlin and Tator , 1977 -RRB-	11084
@NP	the inclined plane test	11084
@NP	Rivlin and Tator , 1977	11109
@NP	Rivlin	11109
@NP	Tator , 1977	11120
@NP	Tator	11120
@NP	1977	11127
@NP	The maximum angle	11134
@NP	the animal	11161
@NP	a stable position	11187
@NP	5 sec on the inclined plane	11209
@NP	5 sec	11209
@NP	the inclined plane	11218
@NP	Nociceptive sensitivity	11251
@NP	a heat-radiation method	11292
@NP	a plantar algesimeter -LRB- Hargreaves et al. , 1988 -RRB-	11322
@NP	a plantar algesimeter	11322
@NP	Hargreaves	11345
@NP	et al. , 1988	11356
@NP	et al.	11356
@NP	1988	11364
@NP	The rat	11371
@NP	a plastic box	11395
@NP	an elevated glass floor	11414
@NP	the bottom of the box	11444
@NP	the bottom	11444
@NP	the box	11458
@NP	the light of a projection lamp -LRB- 150 W -RRB-	11467
@NP	the light	11467
@NP	a projection lamp -LRB- 150 W -RRB-	11480
@NP	a projection lamp	11480
@NP	150 W	11499
@NP	the plantar surface of the hindpaw	11532
@NP	the plantar surface	11532
@NP	the hindpaw	11555
@NP	The time to withdrawal of the heated paw -LRB- withdrawal latency -RRB-	11568
@NP	The time	11568
@NP	withdrawal of the heated paw -LRB- withdrawal latency -RRB-	11580
@NP	withdrawal	11580
@NP	the heated paw -LRB- withdrawal latency -RRB-	11594
@NP	the heated paw	11594
@NP	withdrawal latency	11610
@NP	a time-meter coupled with infrared detectors directed to the plantar surface	11651
@NP	a time-meter	11651
@NP	infrared detectors directed to the plantar surface	11677
@NP	infrared detectors	11677
@NP	the plantar surface	11708
@NP	The maximal time of stimulation	11729
@NP	The maximal time	11729
@NP	stimulation	11749
@NP	40 sec	11776
@NP	skin damage	11792
@NP	The value for a test	11805
@NP	The value	11805
@NP	a test	11819
@NP	the mean of three trials separated by 5 min resting periods	11830
@NP	the mean	11830
@NP	three trials separated by 5 min resting periods	11842
@NP	three trials	11842
@NP	5 min resting periods	11868
@NP	5 min	11868
@NP	periods	11882
@NP	Electrophysiological Evaluation Motor and somatosensory evoked potentials	11891
@NP	Electrophysiological Evaluation Motor	11891
@NP	somatosensory evoked potentials	11933
@NP	somatosensory	11933
@NP	potentials	11954
@NP	the integrity of spinal cord	11991
@NP	the integrity	11991
@NP	spinal cord	12008
@NP	tracts	12045
@NP	Animals	12053
@NP	sodium pentobarbital	12084
@NP	25 mg/kg , i.p.	12106
@NP	25 mg/kg	12106
@NP	a prone position	12137
@NP	a warmed flat coil	12159
@NP	a hot water circulating pump to maintain skin temperature above 32 °C	12192
@NP	a hot water	12192
@NP	pump	12216
@NP	skin temperature	12233
@NP	32 °C	12256
@NP	Motor	12262
@NP	potentials -LRB- MEPs -RRB-	12275
@NP	potentials	12275
@NP	MEPs	12287
@NP	monopolar needle electrodes	12313
@NP	the tibialis anterior muscle	12346
@NP	the contralateral sensorimotor cortex	12382
@NP	single rectangular pulses	12438
@NP	0.1 msec	12467
@NP	duration	12479
@NP	an intensity	12494
@NP	25 mA	12510
@NP	needle electrodes	12535
@NP	the cathode	12578
@NP	the skull overlying the sensorimotor cortex and the anode at the nose	12595
@NP	the skull	12595
@NP	the sensorimotor cortex and the anode	12615
@NP	the sensorimotor cortex	12615
@NP	the anode	12643
@NP	the nose	12656
@NP	This configuration	12666
@NP	transcranial stimulation	12694
@NP	subcortical efferent pathways	12734
@NP	Zappulla	12765
@NP	et al. , 1988 ; García-Alías et al. , 2003	12774
@NP	et al.	12774
@NP	1988 ; García-Alías et al.	12782
@NP	1988	12782
@NP	García-Alías et al.	12788
@NP	García-Alías	12788
@NP	et al.	12801
@NP	2003	12809
@NP	somatosensory evoked potentials -LRB- SSEPs -RRB-	12820
@NP	somatosensory	12820
@NP	potentials -LRB- SSEPs -RRB-	12841
@NP	potentials	12841
@NP	SSEPs	12853
@NP	electrical stimuli of 0.1 msec in duration and 4 mA intensity	12861
@NP	electrical stimuli	12861
@NP	0.1 msec in duration and 4 mA intensity	12883
@NP	0.1 msec	12883
@NP	duration and 4 mA intensity	12895
@NP	duration	12895
@NP	4 mA intensity	12908
@NP	5 Hz to the tibial nerve	12939
@NP	5 Hz	12939
@NP	the tibial nerve	12947
@NP	means of two needle electrodes inserted at the ankle	12967
@NP	means	12967
@NP	two needle electrodes inserted at the ankle	12976
@NP	two needle electrodes	12976
@NP	the ankle	13010
@NP	responses	13028
@NP	two needle electrodes	13058
@NP	the skull	13105
@NP	same sites as stimulation needles for MEPs	13116
@NP	same sites	13116
@NP	stimulation needles for MEPs	13130
@NP	stimulation needles	13130
@NP	MEPs	13154
@NP	A total of 256 responses	13161
@NP	A total	13161
@NP	256 responses	13172
@NP	100 msec following each stimulus	13207
@NP	100 msec	13207
@NP	each stimulus	13226
@NP	The signals	13255
@NP	the oscilloscope -LRB- Sapphire 4ME , Vickers -RRB- to measure the amplitude	13309
@NP	Sapphire 4ME	13327
@NP	Vickers	13341
@NP	the amplitude	13361
@NP	the latency of the evoked potentials -LRB- García-Alías et al. , 2003 -RRB-	13379
@NP	the latency	13379
@NP	the evoked potentials -LRB- García-Alías et al. , 2003 -RRB-	13394
@NP	the	13394
@NP	potentials -LRB- García-Alías et al. , 2003 -RRB-	13405
@NP	potentials	13405
@NP	García-Alías	13417
@NP	et al. , 2003	13430
@NP	et al.	13430
@NP	2003	13438
@NP	reproducibility	13455
@NP	the recording	13471
@NP	needles	13501
@NP	a microscope	13527
@NP	the same placement	13550
@NP	all animals guided by anatomical landmarks	13572
@NP	all animals	13572
@NP	anatomical landmarks	13594
@NP	Immunohistochemical Methods	13616
@NP	functional and electrophysiological tests	13650
@NP	3 , 7 , and 14 dpo	13696
@NP	3	13696
@NP	7	13699
@NP	14 dpo	13706
@NP	5 animals per group and day	13714
@NP	5 animals	13714
@NP	group and day	13728
@NP	4 % paraformaldehyde	13793
@NP	phosphate-buffer saline solution -LRB- PBS , 0.1 M , pH 7.4 -RRB-	13816
@NP	phosphate-buffer saline solution	13816
@NP	PBS	13850
@NP	0.1 M	13855
@NP	pH 7.4	13862
@NP	The spinal cord subjacent to T8 vertebra	13871
@NP	The spinal cord subjacent	13871
@NP	T8 vertebra	13900
@NP	the same solution for 24 h -LRB- lesion block -RRB-	13941
@NP	the same solution	13941
@NP	24 h -LRB- lesion block -RRB-	13963
@NP	24 h	13963
@NP	lesion block	13969
@NP	Segments of about 5 mm of spinal cord proximal and distal to the lesion block	13984
@NP	Segments	13984
@NP	5 mm of spinal cord proximal and distal to the lesion block	14002
@NP	5 mm	14002
@NP	spinal cord proximal and distal to the lesion block	14010
@NP	spinal cord	14010
@NP	the lesion block	14045
@NP	All spinal cord segments -LRB- proximal , lesion and distal blocks -RRB-	14100
@NP	All spinal cord segments	14100
@NP	proximal , lesion and distal blocks	14126
@NP	proximal	14126
@NP	lesion	14136
@NP	distal blocks	14147
@NP	PBS	14184
@NP	30 % sucrose	14199
@NP	4 °C	14225
@NP	Five intact control rats	14230
@NP	anesthetized and perfused trans-cardially	14260
@NP	spinal cords subjacent to T7 , T8 and T9 vertebrae removed and processed	14306
@NP	spinal cords	14306
@NP	T7 , T8 and T9 vertebrae removed and processed	14332
@NP	T7 , T8 and T9 vertebrae	14332
@NP	group CNT	14379
@NP	washes	14943
@NP	sections	14951
@NP	secondary antiserum , donkey anti-rabbit or donkey antimouse Cy2	14980
@NP	secondary antiserum	14980
@NP	donkey anti-rabbit	15001
@NP	donkey antimouse Cy2	15023
@NP	Cy3	15047
@NP	immunoglobulin G -LRB- 1:200 , Jackson Immunoresearch , West Grove , PA -RRB-	15059
@NP	immunoglobulin G	15059
@NP	1:200 , Jackson Immunoresearch , West Grove , PA	15077
@NP	1:200	15077
@NP	Jackson Immunoresearch	15084
@NP	West Grove	15108
@NP	PA	15120
@NP	Cy2 labeled avidin -LRB- 1:200 , Jackson Immunoresearch -RRB- overnight at 4 °C	15128
@NP	Cy2	15128
@NP	avidin -LRB- 1:200 , Jackson Immunoresearch -RRB-	15140
@NP	avidin	15140
@NP	1:200	15148
@NP	Jackson Immunoresearch	15155
@NP	overnight at 4 °C	15179
@NP	overnight	15179
@NP	4 °C	15192
@NP	additional washes	15207
@NP	sections	15226
@NP	gelatin-coated slides	15251
@NP	ethanol	15288
@NP	DPX -LRB- Fluka -RRB-	15313
@NP	DPX	15313
@NP	Fluka	15318
@NP	a control	15329
@NP	some spinal cord sections	15340
@NP	primary antibody	15389
@NP	Samples	15441
@NP	an Olympus BX-51 microscope	15467
@NP	epifluorescence	15509
@NP	appropriate filters	15531
@NP	Double-staining techniques	15552
@NP	the simultaneous visualization of COX-2 and microglial/macrophage cells	15593
@NP	the simultaneous visualization	15593
@NP	COX-2 and microglial/macrophage cells	15627
@NP	LEC labeled	15666
@NP	LEC	15666
@NP	astroglial cells -LRB- GFAP labeled -RRB-	15682
@NP	astroglial cells	15682
@NP	GFAP labeled	15700
@NP	GFAP	15700
@NP	Low power magnification -LRB- x4 -RRB- images of spinal cord sections	15715
@NP	Low power magnification -LRB- x4 -RRB- images	15715
@NP	x4	15740
@NP	spinal cord sections	15754
@NP	the aid	15791
@NP	a digital camera	15802
@NP	Olympus DP50	15820
@NP	the microscope	15846
@NP	NIH Image software	15880
@NP	Spinal cord sections stained for GFAP	15900
@NP	Spinal cord sections	15900
@NP	GFAP	15933
@NP	the area of preserved cord parenchyma	15962
@NP	the area	15962
@NP	preserved cord parenchyma	15974
@NP	high-intensity staining	16009
@NP	reactive astrocytes	16049
@NP	the destroyed parenchyma	16096
@NP	Two independent investigators	16122
@NP	these measurements	16157
@NP	the same images	16181
@NP	the final area of preserved cord parenchyma of each transverse sections analyzed	16198
@NP	the final area	16198
@NP	preserved cord parenchyma of each transverse sections analyzed	16216
@NP	preserved cord parenchyma	16216
@NP	each transverse sections analyzed	16245
@NP	each transverse sections	16245
@NP	the mean value of both subjects	16283
@NP	the mean value	16283
@NP	subjects	16306
@NP	Eight to 10 transverse spinal cord sections per animal	16316
@NP	Eight	16316
@NP	10 transverse spinal cord sections per animal	16325
@NP	10 transverse spinal cord sections	16325
@NP	animal	16364
@NP	Verdú et al. , 2003a	16385
@NP	Verdú	16385
@NP	et al.	16391
@NP	2003a	16399
@NP	Spinal cord sections labeled against COX-2 and VEGF	16407
@NP	Spinal cord sections	16407
@NP	COX-2 and VEGF	16444
@NP	the COX-2 and VEGF staining	16483
@NP	the method described by Acarin et al. -LRB- 1997 -RRB-	16514
@NP	the method	16514
@NP	Acarin	16538
@NP	et al. -LRB- 1997 -RRB-	16545
@NP	et al.	16545
@NP	1997	16553
@NP	The quantitative measurement , referred to as the `` reactivity grade , ''	16560
@NP	The quantitative measurement	16560
@NP	as the `` reactivity grade , ''	16602
@NP	the ratio between immunolabeling density	16644
@NP	the ratio	16644
@NP	immunolabeling density	16662
@NP	spinal cord sections	16688
@NP	lesioned animals -LRB- OEC and DMEM groups -RRB-	16712
@NP	lesioned animals	16712
@NP	OEC and DMEM groups	16730
@NP	OEC	16730
@NP	DMEM groups	16738
@NP	spinal cord sections of unlesioned rats -LRB- CNT group -RRB-	16758
@NP	spinal cord sections	16758
@NP	unlesioned rats -LRB- CNT group -RRB-	16782
@NP	unlesioned rats	16782
@NP	CNT group	16799
@NP	-LRB- math	16834
@NP	equation -RRB- A reactive grade -LRB- mean of three random sections -RRB-	16841
@NP	equation	16841
@NP	A reactive grade -LRB- mean of three random sections -RRB-	16851
@NP	A reactive grade	16851
@NP	mean of three random sections	16869
@NP	mean	16869
@NP	three random sections	16877
@NP	COX-2	16917
@NP	VEGF in each spinal cord block	16931
@NP	VEGF	16931
@NP	each spinal cord block	16939
@NP	Whole spinal cord transverse sections	16963
@NP	these measurements	17015
@NP	variability	17054
@NP	all sections	17067
@NP	each marker and spinal block	17097
@NP	each marker	17097
@NP	spinal block	17113
@NP	lesioned and control animals	17131
@NP	The setting for image acquisition	17191
@NP	The setting	17191
@NP	image acquisition	17207
@NP	the same for all the images	17229
@NP	the same	17229
@NP	all the images	17242
@NP	Spinal cord sections	17258
@NP	LEC	17292
@NP	stains microglia and blood vessels -LRB- Acarin et al. , 1994 -RRB-	17302
@NP	stains microglia and blood vessels	17302
@NP	Acarin	17338
@NP	et al. , 1994	17345
@NP	et al.	17345
@NP	1994	17353
@NP	the number of blood vessel profiles	17383
@NP	the number	17383
@NP	blood vessel profiles	17397
@NP	the grey matter of ventral horns	17422
@NP	the grey matter	17422
@NP	ventral horns	17441
@NP	A grid of 0.04 mm2 -LRB- representing more than 97 % of the horn at x50 -RRB-	17456
@NP	A grid of 0.04 mm2	17456
@NP	A grid	17456
@NP	0.04 mm2	17466
@NP	more than 97 % of the horn at x50	17489
@NP	more than 97 %	17489
@NP	the horn at x50	17506
@NP	the horn	17506
@NP	x50	17518
@NP	each ventral horn and all blood vessel profiles	17538
@NP	each ventral horn	17538
@NP	all blood vessel profiles	17560
@NP	the grid counted	17593
@NP	the grid	17593
@NP	At least five random sections of proximal , lesion , and distal spinal cord	17611
@NP	At least five random sections	17611
@NP	proximal , lesion , and distal spinal cord	17644
@NP	proximal	17644
@NP	lesion	17654
@NP	distal spinal cord	17666
@NP	animal	17696
@NP	The density of blood vessel profiles -LRB- number / mm2 -RRB-	17717
@NP	The density of blood vessel profiles	17717
@NP	The density	17717
@NP	blood vessel profiles	17732
@NP	mm2	17763
@NP	these counts	17788
@NP	Statistical Analysis All	17802
@NP	Statistical Analysis	17802
@NP	All	17823
@NP	functional , electrophysiological and histological measurements	17827
@NP	a `` blinded '' manner	17908
@NP	a code	17934
@NP	rats and histological slices	17944
@NP	rats	17944
@NP	histological slices	17953
@NP	Data	17974
@NP	the mean ± SEM	17992
@NP	Statistical comparisons between groups	18008
@NP	Statistical comparisons	18008
@NP	groups	18040
@NP	nonparametric Kruskal-Wallis and Mann-Whitney U-tests	18060
@NP	nonparametric Kruskal-Wallis	18060
@NP	Mann-Whitney U-tests	18093
@NP	Differences	18115
@NP	p	18158
@NP	The relationships between results of different tests	18168
@NP	The relationships	18168
@NP	results of different tests	18194
@NP	results	18194
@NP	different tests	18205
@NP	lineal regression	18241
@NP	The experimental procedures	18260
@NP	the recommendations of the European Union and the U.S.	18299
@NP	the recommendations	18299
@NP	the European Union and the U.S.	18322
@NP	the European Union	18322
@NP	the U.S.	18345
@NP	Department of Health	18354
@NP	Department	18354
@NP	Health	18368
@NP	the care and use of laboratory animals	18379
@NP	the care and use	18379
@NP	laboratory animals	18399
@NP	the Ethics Committee of our institution	18439
@NP	the Ethics Committee	18439
@NP	our institution	18463
@NP	RESULTS	18481
@NP	1	18495
@NP	AREA	18498
@NP	SPINAL CORD PARENCHYMA -LRB- MM2 -RRB-	18516
@NP	SPINAL CORD PARENCHYMA	18516
@NP	MM2	18540
@NP	PROXIMAL , LESION AND DISTAL SPINAL CORD	18550
@NP	3 , 7 , AND 14 DAYS POSTOPERATION -LRB- DPO -RRB- TABLE 2	18600
@NP	3 , 7	18600
@NP	3	18600
@NP	7	18603
@NP	14 DAYS POSTOPERATION -LRB- DPO -RRB- TABLE 2	18610
@NP	14 DAYS	18610
@NP	POSTOPERATION -LRB- DPO -RRB- TABLE 2	18618
@NP	POSTOPERATION	18618
@NP	DPO	18633
@NP	TABLE 2	18639
@NP	RESULTS OF REGRESSION ANALYSIS OF SEVERAL FUNCTIONAL AND HISTOLOGICAL PARAMETERS	18648
@NP	RESULTS	18648
@NP	REGRESSION ANALYSIS OF SEVERAL FUNCTIONAL AND HISTOLOGICAL PARAMETERS	18659
@NP	REGRESSION ANALYSIS	18659
@NP	SEVERAL FUNCTIONAL AND HISTOLOGICAL PARAMETERS	18682
@NP	SEVERAL	18682
@NP	FUNCTIONAL AND HISTOLOGICAL PARAMETERS	18690
@NP	FUNCTIONAL	18690
@NP	HISTOLOGICAL PARAMETERS	18705
@NP	1	18735
@NP	Histogram representation	18738
@NP	the locomotor activity	18766
@NP	the BBB-score -LRB- A -RRB- , and the time to withdrawal	18802
@NP	the BBB-score -LRB- A -RRB-	18802
@NP	the BBB-score	18802
@NP	A	18817
@NP	the time to withdrawal	18825
@NP	the time	18825
@NP	withdrawal	18837
@NP	the heated paw	18851
@NP	the plantar algesimetry test -LRB- B -RRB-	18869
@NP	the plantar algesimetry test	18869
@NP	B	18899
@NP	time	18907
@NP	DMEM -LRB- open columns -RRB-	18915
@NP	DMEM	18915
@NP	open columns	18921
@NP	OEC -LRB- filled columns -RRB- experimental groups	18939
@NP	OEC -LRB- filled columns -RRB-	18939
@NP	OEC	18939
@NP	columns	18951
@NP	experimental groups	18960
@NP	p < 0.01 -LRB- ** -RRB- versus DMEM group .	18981
@NP	p	18981
@NP	< 0.01 -LRB- ** -RRB-	18983
@NP	<	18983
@NP	0.01 -LRB- ** -RRB-	18985
@NP	0.01	18985
@NP	DMEM group	19002
@NP	Columns	19014
@NP	the mean , and error bars the SEM	19026
@NP	the mean	19026
@NP	error bars the SEM	19040
@NP	error bars	19040
@NP	the SEM	19051
@NP	FIG. 2 .	19061
@NP	FIG.	19061
@NP	2	19066
@NP	Representative recordings of motor	19069
@NP	Representative recordings	19069
@NP	motor	19098
@NP	potentials -LRB- MEPs , left panels -RRB- and somatosensory	19111
@NP	potentials -LRB- MEPs , left panels -RRB-	19111
@NP	potentials	19111
@NP	MEPs , left panels	19123
@NP	MEPs	19123
@NP	panels	19134
@NP	somatosensory	19146
@NP	potentials -LRB- SSEPs , right panels -RRB-	19167
@NP	potentials	19167
@NP	SSEPs , right panels	19179
@NP	SSEPs	19179
@NP	right panels	19186
@NP	intact control rats -LRB- A , B -RRB-	19203
@NP	intact control rats	19203
@NP	A , B	19224
@NP	A	19224
@NP	B	19226
@NP	rats	19236
@NP	group DMEM	19244
@NP	group OEC	19273
@NP	E , F , I , J , M , N	19284
@NP	E	19284
@NP	F	19286
@NP	I	19288
@NP	J	19290
@NP	M	19292
@NP	N	19294
@NP	surgery -LRB- A , B -RRB-	19304
@NP	surgery	19304
@NP	A , B	19313
@NP	A	19313
@NP	B	19315
@NP	3 dpo -LRB- C -- F -RRB-	19322
@NP	C -- F	19329
@NP	C	19329
@NP	F	19331
@NP	7 dpo -LRB- G -- J -RRB-	19335
@NP	G -- J	19342
@NP	G	19342
@NP	J	19344
@NP	14 dpo -LRB- K -- N -RRB-	19352
@NP	K -- N	19360
@NP	K	19360
@NP	N	19362
@NP	Horizontal scale	19366
@NP	= 5 msec and vertical scale	19383
@NP	= 5 msec	19383
@NP	5	19385
@NP	vertical scale	19396
@NP	= 5 mV for all MEP recordings ; horizontal scale = 10	19411
@NP	= 5 mV for all MEP recordings	19411
@NP	= 5 mV	19411
@NP	5	19413
@NP	all MEP recordings	19422
@NP	horizontal scale = 10	19442
@NP	horizontal scale	19442
@NP	10	19461
@NP	msec and vertical scale	19464
@NP	msec	19464
@NP	vertical scale	19473
@NP	= 4 µV for all SSEP recordings	19488
@NP	= 4 µV	19488
@NP	4	19490
@NP	all SSEP recordings	19499
@NP	FIG. 3 .	19521
@NP	FIG.	19521
@NP	3	19526
@NP	Histogram representation of the amplitude of the motor	19529
@NP	Histogram representation	19529
@NP	the amplitude of the motor	19557
@NP	the amplitude	19557
@NP	the motor	19574
@NP	potentials -LRB- MEPs -RRB-	19591
@NP	potentials	19591
@NP	MEPs	19603
@NP	the tibialis anterior muscle -LRB- A -RRB-	19621
@NP	the tibialis anterior muscle	19621
@NP	A	19651
@NP	the amplitudes of the N1 -LRB- B -RRB-	19659
@NP	the amplitudes	19659
@NP	the N1 -LRB- B -RRB-	19677
@NP	the N1	19677
@NP	B	19685
@NP	N2 -LRB- C -RRB-	19689
@NP	N2	19689
@NP	C	19693
@NP	N3	19701
@NP	D	19705
@NP	waves of somatosensory	19708
@NP	waves	19708
@NP	somatosensory	19717
@NP	potentials -LRB- SSEPs -RRB-	19738
@NP	potentials	19738
@NP	SSEPs	19750
@NP	time	19762
@NP	DMEM -LRB- open column -RRB- and OEC	19771
@NP	DMEM -LRB- open column -RRB-	19771
@NP	DMEM	19771
@NP	open column	19777
@NP	OEC	19794
@NP	column	19806
@NP	groups	19814
@NP	p 0.05 -LRB- * -RRB- versus DMEM group	19822
@NP	p 0.05 -LRB- * -RRB-	19822
@NP	p 0.05	19822
@NP	DMEM group	19842
@NP	p < 0.01 -LRB- ** -RRB- versus DMEM group	19854
@NP	p < 0.01 -LRB- ** -RRB-	19854
@NP	p < 0.01	19854
@NP	p <	19854
@NP	p	19854
@NP	0.01	19858
@NP	DMEM group	19875
@NP	Columns	19887
@NP	the mean , and error bars the SEM	19899
@NP	the mean	19899
@NP	error bars the SEM	19913
@NP	error bars	19913
@NP	the SEM	19924
@NP	FIG. 4 .	19934
@NP	FIG.	19934
@NP	4	19939
@NP	Spinal cord sections	19942
@NP	COX-2 -LRB- A -- F -RRB- and VEGF -LRB- G -- L -RRB-	19981
@NP	COX-2	19981
@NP	A -- F	19988
@NP	A	19988
@NP	F	19990
@NP	VEGF	19997
@NP	G -- L	20003
@NP	G	20003
@NP	L	20005
@NP	the lesion site segment	20017
@NP	DMEM -LRB- A -- C , G -- I -RRB- and OEC -LRB- D -- F , J -- L -RRB- groups ,	20046
@NP	DMEM -LRB- A -- C , G -- I -RRB-	20046
@NP	DMEM	20046
@NP	A -- C , G -- I	20052
@NP	A -- C , G --	20052
@NP	C , G	20054
@NP	C	20054
@NP	G	20056
@NP	I	20058
@NP	OEC -LRB- D -- F , J -- L -RRB- groups	20065
@NP	OEC	20065
@NP	D -- F	20070
@NP	D	20070
@NP	F	20072
@NP	J -- L	20075
@NP	J	20075
@NP	L	20077
@NP	groups	20080
@NP	3 dpo -LRB- left -RRB- , 7 dpo -LRB- middle -RRB- , and 14 dpo -LRB- right -RRB-	20091
@NP	3 dpo -LRB- left -RRB-	20091
@NP	left	20098
@NP	7 dpo -LRB- middle -RRB-	20105
@NP	middle	20112
@NP	14 dpo -LRB- right -RRB-	20125
@NP	right	20133
@NP	Images of blood vessel profiles	20141
@NP	Images	20141
@NP	blood vessel profiles	20151
@NP	lectin in the gray matter of DMEM -LRB- M -RRB- and OEC -LRB- N -RRB- groups	20186
@NP	lectin	20186
@NP	the gray matter of DMEM -LRB- M -RRB- and OEC -LRB- N -RRB- groups	20196
@NP	the gray matter of DMEM -LRB- M -RRB-	20196
@NP	the gray matter	20196
@NP	DMEM -LRB- M -RRB-	20215
@NP	DMEM	20215
@NP	M	20221
@NP	OEC -LRB- N -RRB- groups	20228
@NP	OEC	20228
@NP	N	20233
@NP	groups	20236
@NP	Images	20244
@NP	the mean changes in each group	20273
@NP	the mean changes	20273
@NP	each group	20293
@NP	Bar	20305
@NP	1000 µm -LRB- A -- L -RRB- , 50 µm -LRB- M , N -RRB-	20311
@NP	1000 µm -LRB- A -- L -RRB-	20311
@NP	A -- L	20320
@NP	A	20320
@NP	L	20322
@NP	50 µm -LRB- M , N -RRB-	20326
@NP	FIG. 5 .	20340
@NP	FIG.	20340
@NP	5	20345
@NP	Histogram representation of COX-2 and VEGF	20348
@NP	Histogram representation	20348
@NP	COX-2 and VEGF	20376
@NP	quantification	20402
@NP	time in transversal spinal cord sections of DMEM -LRB- open column -RRB- and OEC	20422
@NP	time	20422
@NP	transversal spinal cord sections of DMEM -LRB- open column -RRB- and OEC	20430
@NP	transversal spinal cord sections	20430
@NP	DMEM -LRB- open column -RRB- and OEC	20466
@NP	DMEM -LRB- open column -RRB-	20466
@NP	DMEM	20466
@NP	open column	20472
@NP	OEC	20489
@NP	column	20501
@NP	groups from proximal -LRB- top -RRB- and lesion -LRB- bottom -RRB-	20509
@NP	groups	20509
@NP	proximal -LRB- top -RRB- and lesion -LRB- bottom -RRB-	20521
@NP	proximal	20521
@NP	top	20531
@NP	lesion	20540
@NP	bottom	20548
@NP	spinal cord blocks	20556
@NP	p <	20577
@NP	p	20577
@NP	<	20579
@NP	0.05 versus DMEM group .	20581
@NP	0.05	20581
@NP	DMEM group .	20593
@NP	DMEM	20593
@NP	Columns	20605
@NP	the mean and error bars	20617
@NP	the SEM	20641
@NP	FIG. 6 .	20651
@NP	FIG.	20651
@NP	6	20656
@NP	Double staining for COX-2	20659
@NP	Double staining	20659
@NP	COX-2	20679
@NP	LEC -LRB- red/green -RRB- immunoreactivity in DMEM -LRB- A -RRB-	20685
@NP	LEC -LRB- red/green -RRB- immunoreactivity	20685
@NP	LEC -LRB- red/green -RRB-	20685
@NP	LEC	20685
@NP	red/green	20690
@NP	DMEM -LRB- A -RRB-	20721
@NP	DMEM	20721
@NP	A	20727
@NP	OEC -LRB- B -RRB- groups	20734
@NP	OEC	20734
@NP	B	20739
@NP	groups	20742
@NP	COX	20758
@NP	2/GFAP -LRB- red/green -RRB- immunoreactivity	20763
@NP	2/GFAP -LRB- red/green -RRB-	20763
@NP	2/GFAP	20763
@NP	red/green	20771
@NP	DMEM -LRB- C -RRB- and OEC -LRB- D -RRB-	20802
@NP	DMEM	20802
@NP	C	20808
@NP	OEC	20815
@NP	D	20820
@NP	groups	20823
@NP	the lesion border	20836
@NP	Yellow-orange labeling	20855
@NP	colocalization	20888
@NP	Bar	20904
@NP	50 µm	20910
@NP	Functional Results	20918
@NP	the spinal cord	20954
@NP	all animals	20971
@NP	normal locomotor behavior -LRB- score 21 -RRB-	20990
@NP	normal locomotor behavior	20990
@NP	score 21	21017
@NP	3 dpo	21031
@NP	the BBB-score	21038
@NP	values of 10	21070
@NP	values	21070
@NP	10	21080
@NP	group DMEM and 16	21086
@NP	group DMEM	21086
@NP	16	21101
@NP	group OEC	21107
@NP	The BBB-score	21118
@NP	mean values of 12 and 18 at 7 dpo	21159
@NP	mean values	21159
@NP	12 and 18	21174
@NP	7 dpo	21187
@NP	13 and 20 at 14 dpo in DMEM and OEC groups , respectively -LRB- Fig. 1A -RRB-	21198
@NP	13 and 20	21198
@NP	14 dpo in DMEM and OEC groups , respectively -LRB- Fig. 1A -RRB-	21211
@NP	14 dpo in DMEM and OEC groups , respectively	21211
@NP	14 dpo in DMEM and OEC groups	21211
@NP	14 dpo	21211
@NP	DMEM and OEC groups	21221
@NP	Fig. 1A	21256
@NP	The OEC group	21266
@NP	significantly higher scores	21284
@NP	group DMEM	21317
@NP	all postlesion times	21331
@NP	The preoperative mean values of the maximum angle in the inclined plane	21353
@NP	The preoperative mean values	21353
@NP	the maximum angle in the inclined plane	21385
@NP	the maximum angle	21385
@NP	the inclined plane	21406
@NP	about 48 °	21430
@NP	3 dpo	21444
@NP	the mean maximum angle	21451
@NP	37 °	21487
@NP	41 ° in DMEM and OEC rats , then	21495
@NP	41 °	21495
@NP	DMEM and OEC rats , then	21502
@NP	DMEM and OEC rats	21502
@NP	mean values of 41 ° and 48 ° in DMEM and OEC groups	21559
@NP	mean values of 41 °	21559
@NP	mean values	21559
@NP	41 °	21574
@NP	48 ° in DMEM and OEC groups	21582
@NP	48 °	21582
@NP	DMEM and OEC groups	21589
@NP	14 dpo	21612
@NP	all postoperative days	21627
@NP	the mean maximum angle	21651
@NP	OEC	21702
@NP	DMEM animals	21714
@NP	p < 0.05	21728
@NP	p	21728
@NP	< 0.05	21730
@NP	<	21730
@NP	0.05	21732
@NP	Nociceptive withdrawal responses evaluated by plantar algesimetry	21739
@NP	Nociceptive withdrawal responses	21739
@NP	plantar algesimetry	21785
@NP	a latency of about 9 sec	21809
@NP	a latency	21809
@NP	9 sec	21828
@NP	lesion	21841
@NP	spinal cord lesion	21855
@NP	the mean time of withdrawal of the heated paw	21875
@NP	the mean time	21875
@NP	withdrawal of the heated paw	21892
@NP	withdrawal	21892
@NP	the heated paw	21906
@NP	7 dpo to 22 and 14 sec in DMEM and OEC groups	21934
@NP	7 dpo to 22	21934
@NP	7 dpo	21934
@NP	22	21943
@NP	14 sec in DMEM and OEC groups	21950
@NP	14 sec	21950
@NP	DMEM and OEC groups	21960
@NP	then	21995
@NP	group DMEM	22013
@NP	18 seconds	22027
@NP	group OEC	22061
@NP	The withdrawal latency	22072
@NP	OEC	22122
@NP	DMEM animals	22134
@NP	follow-up -LRB- Fig. 1B -RRB-	22154
@NP	follow-up	22154
@NP	Fig. 1B	22165
@NP	Electrophysiological Results MEPs recorded prior to operation	22175
@NP	Electrophysiological Results	22175
@NP	MEPs	22204
@NP	operation	22227
@NP	a single wave	22244
@NP	a mean latency of about 6 msec	22263
@NP	a mean latency	22263
@NP	6 msec	22287
@NP	amplitude of about 15 mV	22303
@NP	amplitude	22303
@NP	about 15 mV	22316
@NP	both groups -LRB- Fig. 2 -RRB-	22331
@NP	both groups	22331
@NP	Fig. 2	22344
@NP	photochemical injury	22359
@NP	no changes in the latency	22381
@NP	no changes	22381
@NP	the latency	22395
@NP	follow-up	22428
@NP	the amplitude	22443
@NP	both groups	22479
@NP	3 dpo	22494
@NP	10 and 15 mV	22542
@NP	DMEM and OEC groups , respectively at 14 dpo ,	22558
@NP	DMEM and OEC groups	22558
@NP	14 dpo	22595
@NP	significant differences in favor of group OEC at 7 and 14	22608
@NP	significant differences	22608
@NP	favor of group OEC at 7 and 14	22635
@NP	favor	22635
@NP	group OEC at 7 and 14	22644
@NP	group OEC	22644
@NP	7 and 14	22657
@NP	Figs. 2 and 3	22671
@NP	Figs. 2	22671
@NP	3	22683
@NP	Control SSEPs	22687
@NP	a series	22708
@NP	negative peaks	22733
@NP	latencies of 14 , 20 , and 29 msec	22751
@NP	latencies	22751
@NP	14 , 20 , and 29 msec	22764
@NP	14	22764
@NP	20	22768
@NP	29 msec	22776
@NP	N1 , N2 , and N3 waves	22794
@NP	mean amplitudes of 9 , 16 , and 14 µV , respectively -LRB- Fig. 2 -RRB-	22821
@NP	mean amplitudes	22821
@NP	9 , 16 , and 14 µV , respectively -LRB- Fig. 2 -RRB-	22840
@NP	9 , 16 , and 14 µV , respectively	22840
@NP	9 , 16 , and 14	22840
@NP	µV	22854
@NP	Fig. 2	22872
@NP	spinal cord injury	22887
@NP	the amplitude of the three waves	22907
@NP	the amplitude	22907
@NP	the three waves	22924
@NP	group OEC	22968
@NP	group DMEM at all postoperative test days -LRB- Figs. 2 and 3 -RRB-	22986
@NP	group DMEM	22986
@NP	all postoperative test days -LRB- Figs. 2 and 3 -RRB-	23000
@NP	all postoperative test days	23000
@NP	Figs. 2 and 3	23029
@NP	Figs. 2	23029
@NP	3	23041
@NP	Histological Results	23045
@NP	group DMEM	23069
@NP	transverse spinal cord sections from T8 spinal cord segment	23081
@NP	transverse spinal cord sections	23081
@NP	T8 spinal cord segment	23118
@NP	lesion block	23142
@NP	a cavity affecting the dorsal	23163
@NP	a cavity	23163
@NP	the dorsal	23182
@NP	the central canal	23209
@NP	parenchyma partially involving the lateral funiculi	23238
@NP	parenchyma	23238
@NP	the lateral funiculi	23269
@NP	14 dpo -LRB- Fig. 4 -RRB-	23302
@NP	14 dpo	23302
@NP	Fig. 4	23310
@NP	3 dpo	23322
@NP	group OEC	23332
@NP	spinal cord sections from the lesion level	23343
@NP	spinal cord sections	23343
@NP	the lesion level	23369
@NP	a smaller cavity	23393
@NP	only the dorsal funiculus	23420
@NP	7 and 14 dpo	23455
@NP	7	23455
@NP	14 dpo	23461
@NP	dorsolateral areas -LRB- Fig. 4 -RRB-	23482
@NP	dorsolateral areas	23482
@NP	Fig. 4	23502
@NP	14 dpo	23514
@NP	5 of 5 DMEM rats	23525
@NP	5	23525
@NP	5 DMEM rats	23530
@NP	3 of 5 OEC rats	23549
@NP	3	23549
@NP	5 OEC rats	23554
@NP	sections from proximal and distal blocks	23566
@NP	sections	23566
@NP	proximal and distal blocks	23580
@NP	parenchyma in the dorsal funiculus	23624
@NP	parenchyma	23624
@NP	the dorsal funiculus	23638
@NP	The average area of preserved spinal cord	23660
@NP	The average area	23660
@NP	preserved spinal cord	23680
@NP	3 to 14 dpo	23717
@NP	experimental groups	23737
@NP	the three spinal levels studied	23760
@NP	the three spinal levels	23760
@NP	The area of preserved spinal cord	23793
@NP	The area	23793
@NP	preserved spinal cord	23805
@NP	group OEC	23855
@NP	group DMEM	23873
@NP	the three intervals evaluated -LRB- Table 1 -RRB-	23887
@NP	the three intervals	23887
@NP	Table 1	23918
@NP	COX-2 immunoreactivity .	23928
@NP	COX-2	23928
@NP	immunoreactivity	23934
@NP	COX-2 staining	23952
@NP	spinal cord sections from lesioned rats with respect	23980
@NP	spinal cord sections	23980
@NP	lesioned rats with respect	24006
@NP	lesioned rats	24006
@NP	respect	24025
@NP	rats	24044
@NP	group DMEM	24053
@NP	at 3 and 7 dpo sections from the T8 spinal cord segment	24065
@NP	at 3 and 7 dpo sections	24065
@NP	the T8 spinal cord segment	24094
@NP	intense COX	24128
@NP	2 staining in spinal parenchyma	24141
@NP	2 staining	24141
@NP	spinal parenchyma	24155
@NP	the cavity -LRB- Fig. 4A , B -RRB-	24185
@NP	the cavity	24185
@NP	Fig. 4A , B	24197
@NP	Fig. 4A	24197
@NP	B	24205
@NP	3 dpo	24212
@NP	sections of group OEC	24222
@NP	sections	24222
@NP	group OEC	24234
@NP	COX - 2 staining	24245
@NP	COX	24245
@NP	2 staining	24250
@NP	spinal cord parenchyma	24277
@NP	the cavity , and spread to ventral grey matter	24312
@NP	the cavity , and spread	24312
@NP	ventral grey matter	24338
@NP	white matter of lateral and ventral funiculi -LRB- Fig. 4D -RRB-	24362
@NP	white matter	24362
@NP	lateral and ventral funiculi -LRB- Fig. 4D -RRB-	24378
@NP	lateral and ventral funiculi	24378
@NP	Fig. 4D	24408
@NP	7 dpo	24421
@NP	COX-2 staining	24428
@NP	the spinal cord parenchyma around the cavity	24462
@NP	the spinal cord parenchyma	24462
@NP	the cavity	24496
@NP	the tissue filling the cavity -LRB- Fig. 4E -RRB-	24514
@NP	the tissue	24514
@NP	the cavity -LRB- Fig. 4E -RRB-	24533
@NP	the cavity	24533
@NP	Fig. 4E	24545
@NP	14 dpo	24558
@NP	lower COX-2 staining	24566
@NP	lower COX-2	24566
@NP	staining	24578
@NP	the tissue that filled the cavity	24603
@NP	the tissue	24603
@NP	the cavity	24626
@NP	the cord parenchyma in both groups -LRB- Fig. 4C , F -RRB-	24649
@NP	the cord parenchyma	24649
@NP	both groups -LRB- Fig. 4C , F -RRB-	24672
@NP	both groups	24672
@NP	Fig. 4C , F	24685
@NP	Fig. 4C	24685
@NP	F	24693
@NP	the lesion block	24700
@NP	the mean COX-2 reactivity grade at 3 dpo	24718
@NP	the mean COX-2 reactivity grade	24718
@NP	3 dpo	24753
@NP	about 4 and 8	24763
@NP	DMEM and OEC groups	24780
@NP	both groups	24847
@NP	1.5 at 14 dpo	24868
@NP	1.5	24868
@NP	14 dpo	24875
@NP	The COX-2 reactivity grade	24883
@NP	OEC	24938
@NP	DMEM group	24950
@NP	3 and 7 dpo -LRB- Fig. 5 -RRB-	24964
@NP	3 and 7 dpo	24964
@NP	Fig. 5	24977
@NP	spinal cord sections from the proximal block	24989
@NP	spinal cord sections	24989
@NP	the proximal block	25015
@NP	the COX-2 reactivity grade	25035
@NP	3 and 5	25077
@NP	DMEM and OEC groups -LRB- p < 0.05 -RRB-	25088
@NP	DMEM and OEC groups	25088
@NP	p < 0.05	25109
@NP	p	25109
@NP	< 0.05	25111
@NP	<	25111
@NP	0.05	25113
@NP	3 dpo	25137
@NP	3	25167
@NP	7 dpo and 2	25172
@NP	7 dpo	25172
@NP	2	25182
@NP	14 dpo in both groups	25187
@NP	14 dpo	25187
@NP	both groups	25197
@NP	the distal block sections	25213
@NP	the COX-2 reactivity grade	25240
@NP	6 and 5	25276
@NP	DMEM and OEC groups	25287
@NP	3 dpo	25325
@NP	group DMEM	25343
@NP	the COX-2 reactivity grade	25354
@NP	2	25394
@NP	14 dpo	25399
@NP	group OEC	25410
@NP	it	25420
@NP	7	25436
@NP	7 dpo	25441
@NP	Significant differences	25468
@NP	DMEM and OEC groups	25511
@NP	7 dpo -LRB- Fig. 5 -RRB-	25534
@NP	7 dpo	25534
@NP	Fig. 5	25541
@NP	Double staining COX-2	25550
@NP	Double staining	25550
@NP	COX-2	25566
@NP	GFAP and COX-2	25572
@NP	GFAP	25572
@NP	COX-2	25581
@NP	LEC	25587
@NP	Double staining for COX-2 and GFAP	25592
@NP	Double staining	25592
@NP	COX-2 and GFAP	25612
@NP	3 dpo	25649
@NP	sections of group DMEM	25659
@NP	sections	25659
@NP	group DMEM	25671
@NP	very few cells	25683
@NP	COX-2 and GFAP	25715
@NP	contrast	25734
@NP	OEC rats	25747
@NP	areas of COX-2 -- and GFAP-positive parenchyma	25757
@NP	areas	25757
@NP	COX-2 -- and GFAP-positive parenchyma	25766
@NP	COX-2	25766
@NP	GFAP-positive parenchyma	25777
@NP	Fig. 6C , D	25822
@NP	Fig. 6C	25822
@NP	D	25830
@NP	Double labeling against COX-2 and LEC	25834
@NP	Double labeling	25834
@NP	COX-2 and LEC	25858
@NP	overlapping of both markers	25884
@NP	overlapping	25884
@NP	both markers	25899
@NP	spinal cord sections in group DMEM	25931
@NP	spinal cord sections	25931
@NP	group DMEM	25955
@NP	group OEC -LRB- Fig. 6A , B -RRB-	25974
@NP	group OEC	25974
@NP	Fig. 6A , B	25985
@NP	Fig. 6A	25985
@NP	B	25993
@NP	7 dpo	26000
@NP	sections of group DMEM	26010
@NP	sections	26010
@NP	group DMEM	26022
@NP	COX-2 staining	26034
@NP	LEC-positive round cells	26077
@NP	sections from group OEC	26114
@NP	sections	26114
@NP	group OEC	26128
@NP	COX-2 staining	26139
@NP	GFAP-positive cells	26166
@NP	LEC-positive cells that filled and surrounded the cavity	26198
@NP	LEC-positive cells	26198
@NP	the cavity	26244
@NP	14 dpo	26259
@NP	both experimental groups	26270
@NP	COX-2 staining	26296
@NP	LEC-positive cells in the cavity	26332
@NP	LEC-positive cells	26332
@NP	the cavity	26354
@NP	The same temporal pattern	26366
@NP	spinal cord sections	26408
@NP	proximal and distal blocks	26434
@NP	VEGF immunoreactivity .	26462
@NP	VEGF	26462
@NP	immunoreactivity	26467
@NP	VEGF staining	26485
@NP	spinal cord sections	26521
@NP	lesioned rats with respect	26547
@NP	lesioned rats	26547
@NP	respect	26566
@NP	unoperated animals	26577
@NP	3 dpo	26600
@NP	sections from the lesion block of both groups	26610
@NP	sections	26610
@NP	the lesion block of both groups	26624
@NP	the lesion block	26624
@NP	both groups	26644
@NP	VEGF-immunoreactivity	26657
@NP	all the spinal cord parenchyma	26695
@NP	grey and white matter -LRB- Fig. 4G , J -RRB-	26737
@NP	grey and white matter	26737
@NP	Fig. 4G , J	26760
@NP	Fig. 4G	26760
@NP	J	26768
@NP	7 dpo	26775
@NP	the levels of VEGF staining	26782
@NP	the levels	26782
@NP	VEGF staining	26796
@NP	group DMEM -LRB- Fig. 4H -RRB-	26823
@NP	group DMEM	26823
@NP	Fig. 4H	26835
@NP	group OEC -LRB- Fig. 4K -RRB-	26861
@NP	group OEC	26861
@NP	Fig. 4K	26872
@NP	significantly higher reactivity grade -LRB- Fig. 5 -RRB-	26886
@NP	significantly higher reactivity grade	26886
@NP	Fig. 5	26925
@NP	the grey matter	26949
@NP	higher VEGF staining	26972
@NP	the white matter	26998
@NP	14 dpo	27019
@NP	VEGF staining	27027
@NP	both groups -LRB- Fig. 4I , L -RRB-	27056
@NP	both groups	27056
@NP	Fig. 4I , L	27069
@NP	Fig. 4I	27069
@NP	L	27077
@NP	spinal cord sections from the proximal block	27084
@NP	spinal cord sections	27084
@NP	the proximal block	27110
@NP	the mean VEGF reactivity grade	27130
@NP	time postinjury	27190
@NP	3 and 7 dpo in group OEC	27239
@NP	3 and 7 dpo	27239
@NP	group OEC	27254
@NP	group DMEM -LRB- Fig. 5 -RRB-	27272
@NP	group DMEM	27272
@NP	Fig. 5	27284
@NP	The VEGF reactivity grade	27293
@NP	sections	27341
@NP	the distal block	27361
@NP	group OEC	27407
@NP	7 dpo with respect	27425
@NP	7 dpo	27425
@NP	respect	27436
@NP	group DMEM	27447
@NP	Density of blood vessels .	27459
@NP	Density	27459
@NP	blood vessels	27470
@NP	spinal cord sections subjacent to T8 vertebra from unlesioned rats	27488
@NP	spinal cord sections	27488
@NP	T8 vertebra from unlesioned rats	27522
@NP	T8 vertebra	27522
@NP	unlesioned rats	27539
@NP	the average density of blood vessel profiles	27556
@NP	the average density	27556
@NP	blood vessel profiles	27579
@NP	515 ± 21 blood vessels / mm2	27605
@NP	515 ± 21 blood vessels	27605
@NP	515 ±	27605
@NP	21 blood vessels	27611
@NP	mm2	27629
@NP	The density of blood vessel profiles	27634
@NP	The density	27634
@NP	blood vessel profiles	27649
@NP	378 ± 17 in group DMEM and 369 ± 9 blood vessels/mm2	27675
@NP	378 ± 17 in group DMEM	27675
@NP	378 ± 17	27675
@NP	group DMEM	27687
@NP	369 ± 9 blood vessels/mm2	27702
@NP	369 ±	27702
@NP	9 blood vessels/mm2	27708
@NP	group OEC at 3 dpo	27731
@NP	group OEC	27731
@NP	3 dpo	27744
@NP	It	27751
@NP	491 ±	27778
@NP	43 and 604 ± 27	27784
@NP	7 dpo	27803
@NP	512 ±	27816
@NP	25 and 687	27822
@NP	± 32 blood vessels/mm2 at 14 dpo	27833
@NP	± 32 blood vessels/mm2	27833
@NP	14 dpo	27859
@NP	groups DMEM and OEC	27869
@NP	The mean density of blood vessel profiles	27904
@NP	The mean density	27904
@NP	blood vessel profiles	27924
@NP	group OEC	27974
@NP	group DMEM	27992
@NP	7 -LRB- p < 0.05 -RRB- and 14 dpo -LRB- p < 0.01 -RRB- -LRB- Fig. 4 -RRB-	28006
@NP	7 -LRB- p < 0.05 -RRB-	28006
@NP	7	28006
@NP	p < 0.05	28009
@NP	p	28009
@NP	< 0.05	28011
@NP	<	28011
@NP	0.05	28013
@NP	14 dpo -LRB- p < 0.01 -RRB- -LRB- Fig. 4 -RRB-	28023
@NP	14 dpo -LRB- p < 0.01 -RRB-	28023
@NP	p < 0.01	28031
@NP	p	28031
@NP	< 0.01	28033
@NP	<	28033
@NP	0.01	28034
@NP	Fig. 4	28041
@NP	spinal cord sections subjacent to T7 vertebra from control rats	28053
@NP	spinal cord sections	28053
@NP	T7 vertebra from control rats	28087
@NP	T7 vertebra	28087
@NP	control rats	28104
@NP	the density of blood vessel profiles	28118
@NP	the density	28118
@NP	blood vessel profiles	28133
@NP	512 ±	28164
@NP	13 blood vessels/mm2	28170
@NP	spinal cord sections from proximal cord blocks	28195
@NP	spinal cord sections	28195
@NP	proximal cord blocks	28221
@NP	the density	28243
@NP	410 ± 14 and 389 ± 26 blood vessels/mm2	28259
@NP	410 ± 14	28259
@NP	410 ±	28259
@NP	14	28265
@NP	389 ± 26 blood vessels/mm2	28272
@NP	389 ±	28272
@NP	26 blood vessels/mm2	28278
@NP	3 dpo in groups DMEM and OEC	28302
@NP	3 dpo	28302
@NP	groups DMEM and OEC	28311
@NP	It	28346
@NP	487 ±	28362
@NP	41 and 533 ± 18	28368
@NP	7 dpo	28387
@NP	559	28401
@NP	± 19 and 665 ± 26 -LRB- p < 0.01 -RRB-	28405
@NP	± 19 and 665 ± 26	28405
@NP	p < 0.01	28424
@NP	p	28424
@NP	< 0.01	28426
@NP	<	28426
@NP	0.01	28428
@NP	blood vessels/mm2	28434
@NP	14 dpo	28455
@NP	groups DMEM and OEC	28465
@NP	spinal cord subjacent to T9 vertebra from unlesioned rats	28503
@NP	spinal cord subjacent	28503
@NP	T9 vertebra from unlesioned rats	28528
@NP	T9 vertebra	28528
@NP	unlesioned rats	28545
@NP	the density of blood vessels	28561
@NP	the density	28561
@NP	blood vessels	28576
@NP	517 ± 4 blood vessels/mm2	28594
@NP	517 ±	28594
@NP	4 blood vessels/mm2	28600
@NP	the distal block sections of injured rats	28624
@NP	the distal block sections	28624
@NP	injured rats	28653
@NP	the density	28666
@NP	400 ± 14 and 427	28682
@NP	± 10 blood vessels/mm2	28699
@NP	3 dpo , 470 ±	28725
@NP	3 dpo	28725
@NP	470 ±	28732
@NP	32 and 532 ± 20 blood vessels/mm2 at 7 dpo	28738
@NP	32 and 532 ± 20 blood vessels/mm2	28738
@NP	7 dpo	28775
@NP	590 ± 14 and 666 ± 15 -LRB- p < 0.01 -RRB-	28786
@NP	590	28786
@NP	± 14 and 666 ± 15 -LRB- p < 0.01 -RRB-	28790
@NP	± 14 and 666 ± 15	28790
@NP	p < 0.01	28809
@NP	p	28809
@NP	< 0.01	28811
@NP	<	28811
@NP	0.01	28813
@NP	blood vessels/mm2	28819
@NP	14 dpo in groups DMEM and OEC	28840
@NP	14 dpo	28840
@NP	groups DMEM and OEC	28850
@NP	Functional and histological correlations .	28885
@NP	Functional and histological correlations	28885
@NP	Functional	28885
@NP	histological correlations	28900
@NP	Table 2	28927
@NP	the results of the regression analysis of functional and histological parameters	28941
@NP	the results	28941
@NP	the regression analysis of functional and histological parameters	28956
@NP	the regression analysis	28956
@NP	functional and histological parameters	28983
@NP	a biochemical chain reaction	29026
@NP	the COX-2 reactivity grade seen at 3 dpo	29056
@NP	the COX-2 reactivity grade	29056
@NP	3 dpo	29091
@NP	the VEGF reactivity grade	29131
@NP	7 dpo	29160
@NP	this VEGF reactivity grade	29171
@NP	the density of blood vessel profiles	29237
@NP	the density	29237
@NP	blood vessel profiles	29252
@NP	14 dpo	29277
@NP	DISCUSSION The results of this study	29286
@NP	DISCUSSION The results	29286
@NP	DISCUSSION	29286
@NP	The results	29297
@NP	this study	29312
@NP	the lesion site	29337
@NP	the reactivity of COX-2 and VEGF	29354
@NP	the reactivity	29354
@NP	COX-2 and VEGF	29372
@NP	spinal cord sections in OEC-transplanted	29418
@NP	spinal cord sections	29418
@NP	OEC-transplanted	29442
@NP	DMEM-injected rats during the first week postlesion	29473
@NP	DMEM-injected rats	29473
@NP	the first week postlesion	29499
@NP	addition	29529
@NP	the density of blood vessel profiles in the ventral gray matter	29539
@NP	the density	29539
@NP	blood vessel profiles in the ventral gray matter	29554
@NP	blood vessel profiles	29554
@NP	the ventral gray matter	29579
@NP	spinal cord sections	29631
@NP	group OEC	29657
@NP	group DMEM	29677
@NP	accordance with previous studies	29692
@NP	accordance	29692
@NP	previous studies	29708
@NP	the photochemical injury	29726
@NP	the dorsal	29760
@NP	dosolateral funiculi of the spinal cord -LRB- Verdú et al. , 2003b -RRB-	29775
@NP	dosolateral funiculi	29775
@NP	the spinal cord -LRB- Verdú et al. , 2003b -RRB-	29799
@NP	the spinal cord	29799
@NP	Verdú	29816
@NP	et al. , 2003b	29822
@NP	et al.	29822
@NP	2003b	29830
@NP	the area of preserved cord parenchyma	29842
@NP	the area	29842
@NP	preserved cord parenchyma	29854
@NP	OEC transplantation -LRB- Verdú et al. , 2003a -RRB-	29911
@NP	OEC transplantation	29911
@NP	Verdú	29932
@NP	et al. , 2003a	29938
@NP	et al.	29938
@NP	2003a	29946
@NP	comparison with rats that received an injection of medium	29957
@NP	comparison	29957
@NP	rats that received an injection of medium	29973
@NP	rats	29973
@NP	an injection of medium	29992
@NP	an injection	29992
@NP	medium	30008
@NP	OEC-transplanted rats	30016
@NP	better locomotor function	30045
@NP	normal nociceptive responses	30085
@NP	the electrophysiological results	30123
@NP	the amplitude of motor and somatosensory	30171
@NP	the amplitude	30171
@NP	motor and somatosensory	30188
@NP	potentials	30219
@NP	OECs	30258
@NP	DMEM-injected rats	30272
@NP	evidence of functional preservation of descending and ascending spinal pathways	30302
@NP	evidence	30302
@NP	functional preservation of descending and ascending spinal pathways	30314
@NP	functional preservation	30314
@NP	spinal pathways	30366
@NP	Spontaneous recovery of the functional loss	30383
@NP	Spontaneous recovery	30383
@NP	the functional loss	30407
@NP	experimental animals or humans	30461
@NP	the early days or weeks	30500
@NP	partial spinal cord injuries -LRB- Tator , 1998 -RRB-	30530
@NP	partial spinal cord injuries	30530
@NP	Tator	30560
@NP	1998	30567
@NP	Several mechanisms	30574
@NP	such recovery	30608
@NP	especially reduction of edema and hematomyelia	30623
@NP	especially reduction	30623
@NP	edema and hematomyelia	30647
@NP	the resolution of the primary and secondary injury insults	30674
@NP	the resolution	30674
@NP	the primary and secondary injury insults	30692
@NP	Little et al. , 1999	30734
@NP	Little	30734
@NP	et al.	30741
@NP	1999	30749
@NP	The progressive decrease of the spinal cord tissue area	30756
@NP	The progressive decrease	30756
@NP	the spinal cord tissue area	30784
@NP	the functional recovery	30825
@NP	the first two weeks	30865
@NP	injury in the present study	30891
@NP	injury	30891
@NP	the present study	30901
@NP	the reduction of edema	30942
@NP	the reduction	30942
@NP	edema	30959
@NP	OEC-transplanted rats	30980
@NP	a better neurological and electrophysiological recovery	31006
@NP	smaller cord tissue loss than DMEM-injected rats	31070
@NP	smaller cord tissue loss	31070
@NP	DMEM-injected rats	31100
@NP	The photochemical	31120
@NP	lesion	31146
@NP	the spinal dorsal columns	31162
@NP	animals of the OEC group	31191
@NP	animals	31191
@NP	the OEC group	31202
@NP	the lateral funiculi in the DMEM-injected rats	31235
@NP	the lateral funiculi	31235
@NP	the DMEM-injected rats	31259
@NP	This reduction in the extent of the lesion	31283
@NP	This reduction	31283
@NP	the extent of the lesion	31301
@NP	the extent	31301
@NP	the lesion	31315
@NP	the considerably improved functional and electrophysiological outcome	31338
@NP	rats with OEC transplant	31411
@NP	rats	31411
@NP	OEC transplant	31421
@NP	Spinal cord injuries	31437
@NP	localized within the dorsal columns	31470
@NP	the dorsal	31487
@NP	mild functional motor deficits	31514
@NP	lesions affecting also the ventral and lateral funiculi	31554
@NP	lesions	31554
@NP	the ventral and lateral funiculi	31577
@NP	severe motor deficits	31616
@NP	Adamson	31639
@NP	et al. , 1989	31647
@NP	et al.	31647
@NP	1989	31655
@NP	Kawai and Nagao , 1992	31661
@NP	Kawai and Nagao	31661
@NP	1992	31678
@NP	Schlag et al. , 2001	31684
@NP	Schlag	31684
@NP	et al. , 2001	31691
@NP	et al.	31691
@NP	2001	31699
@NP	Schucht et al. , 2002	31705
@NP	Schucht	31705
@NP	et al. , 2002	31713
@NP	et al.	31713
@NP	2002	31721
@NP	The results	31728
@NP	the density of blood vessel profiles	31750
@NP	the density	31750
@NP	blood vessel profiles	31765
@NP	about 30 % in OEC-transplanted rats	31797
@NP	about 30 %	31797
@NP	OEC-transplanted rats	31810
@NP	respect	31837
@NP	unlesioned rats	31848
@NP	the COX-2 and VEGF reactivity grade	31869
@NP	about 8 - and 6-fold higher in OECtransplanted rats	31909
@NP	8	31915
@NP	OECtransplanted	31939
@NP	unlesioned animals	31968
@NP	Significant positive correlations	31988
@NP	COX-2 and VEGF reactivity grades	32041
@NP	VEGF reactivity grade and density of blood vessels	32083
@NP	VEGF reactivity grade	32083
@NP	density of blood vessels	32109
@NP	density	32109
@NP	blood vessels	32120
@NP	density of blood vessels	32147
@NP	density	32147
@NP	blood vessels	32158
@NP	preserved spinal cord parenchyma -LRB- Table 2 -RRB-	32176
@NP	preserved spinal cord parenchyma	32176
@NP	Table 2	32210
@NP	It	32220
@NP	OECs transplanted into the lesioned cord	32240
@NP	OECs	32240
@NP	the lesioned cord	32263
@NP	these responses	32302
@NP	In vitro OECs	32319
@NP	several neurotrophic molecules	32341
@NP	nerve growth factor -LRB- NGF -RRB-	32380
@NP	nerve growth factor	32380
@NP	NGF	32401
@NP	brain-derived neurotrophic factor -LRB- BDNF -RRB-	32407
@NP	brain-derived neurotrophic factor	32407
@NP	BDNF	32442
@NP	neurotrophin 4/5	32449
@NP	neurotrophin	32449
@NP	4/5	32462
@NP	glial cell linederived neurotrophic factor -LRB- GDNF -RRB-	32467
@NP	glial cell linederived neurotrophic factor	32467
@NP	glial cell	32467
@NP	neurotrophic factor	32490
@NP	GDNF	32511
@NP	their receptors	32521
@NP	Ramón-Cueto	32538
@NP	et al. , 1993	32550
@NP	et al.	32550
@NP	1993	32558
@NP	Boruch et al. , 2001	32564
@NP	Boruch	32564
@NP	et al. , 2001	32571
@NP	et al.	32571
@NP	2001	32579
@NP	Woodhall et al. , 2001	32585
@NP	Woodhall	32585
@NP	et al. , 2001	32594
@NP	et al.	32594
@NP	2001	32602
@NP	Lipson et al. , 2003	32608
@NP	Lipson	32608
@NP	et al. , 2003	32615
@NP	et al.	32615
@NP	2003	32623
@NP	Vincent et al. , 2003	32629
@NP	Vincent	32629
@NP	et al. , 2003	32637
@NP	et al.	32637
@NP	2003	32645
@NP	Au and Roskams -LRB- 2003 -RRB-	32662
@NP	Au and Roskams	32662
@NP	2003	32678
@NP	OECs from lamina propia , which display Schwann-like properties ,	32698
@NP	OECs	32698
@NP	lamina propia	32708
@NP	Schwann-like properties	32737
@NP	VEGF and PACAP	32775
@NP	it	32805
@NP	OECs	32822
@NP	all these molecules in vivo	32847
@NP	all these molecules	32847
@NP	vivo	32870
@NP	transplantation	32881
@NP	The results reported in the present study	32898
@NP	The results	32898
@NP	the present study	32922
@NP	the first evidence	32948
@NP	transplanted OECs	32972
@NP	functional recovery	32998
@NP	loss of cord parenchyma	33030
@NP	loss	33030
@NP	cord parenchyma	33038
@NP	incomplete spinal cord injury by means of neoangiogenesis	33060
@NP	incomplete spinal cord injury	33060
@NP	means of neoangiogenesis	33093
@NP	means	33093
@NP	neoangiogenesis	33102
@NP	upregulation of COX-2 and VEGF	33135
@NP	upregulation	33135
@NP	COX-2 and VEGF	33151
@NP	intact spinal cord	33170
@NP	COX-2 mRNA and protein	33190
@NP	COX-2 mRNA	33190
@NP	protein	33205
@NP	neurons of all laminae	33232
@NP	neurons	33232
@NP	all laminae	33243
@NP	white matter	33262
@NP	glial cells	33275
@NP	astrocytes -LRB- Vanegas and Schaible , 2001 -RRB-	33304
@NP	astrocytes	33304
@NP	Vanegas and Schaible	33316
@NP	2001	33338
@NP	injury	33351
@NP	COX-2 and PGE2 immunoreactivity	33359
@NP	protein levels	33395
@NP	Resnick et al. , 1998 ; Hirst et al. , 1999 ; Hains et al. , 2001	33411
@NP	Resnick	33411
@NP	et al. , 1998 ; Hirst et al. , 1999 ; Hains et al. , 2001	33419
@NP	et al. , 1998	33419
@NP	et al.	33419
@NP	1998	33427
@NP	Hirst et al. , 1999	33433
@NP	Hirst	33433
@NP	et al. , 1999	33439
@NP	et al.	33439
@NP	1999	33447
@NP	Hains et al. , 2001	33453
@NP	Hains	33453
@NP	et al. , 2001	33459
@NP	et al.	33459
@NP	2001	33467
@NP	the lesion site	33486
@NP	high levels	33519
@NP	the first 14 days postinjury	33538
@NP	A number of in vivo studies	33568
@NP	A number	33568
@NP	vivo studies	33583
@NP	inhibition of COX	33614
@NP	inhibition	33614
@NP	COX	33628
@NP	a protective effect against ischemic damage -LRB- Yamamoto et al. , 1995 -RRB-	33636
@NP	a protective effect	33636
@NP	ischemic damage -LRB- Yamamoto et al. , 1995 -RRB-	33664
@NP	ischemic damage	33664
@NP	Yamamoto	33681
@NP	et al. , 1995	33690
@NP	et al.	33690
@NP	1995	33698
@NP	kainic-acid	33705
@NP	neurotoxicity -LRB- Baran et al. , 1994 -RRB-	33725
@NP	neurotoxicity	33725
@NP	Baran	33740
@NP	et al. , 1994	33746
@NP	et al.	33746
@NP	1994	33754
@NP	spinal cord contusion -LRB- Resnick et al. , 1998 ; Hains et al. , 2001 -RRB-	33765
@NP	spinal cord contusion	33765
@NP	Resnick	33788
@NP	et al. , 1998 ; Hains et al. , 2001	33796
@NP	et al.	33796
@NP	1998 ; Hains et al.	33804
@NP	1998	33804
@NP	Hains et al.	33810
@NP	Hains	33810
@NP	et al.	33816
@NP	2001	33824
@NP	The cytotoxicity of COX-2	33831
@NP	The cytotoxicity	33831
@NP	COX-2	33851
@NP	part	33876
@NP	generation	33884
@NP	reactive oxygen species	33898
@NP	the peroxidase step	33934
@NP	the COX reaction	33957
@NP	PGG2	33983
@NP	PGH2 -LRB- Tsai et al. , 1994 -RRB-	34004
@NP	PGH2	34004
@NP	Tsai	34010
@NP	et al. , 1994	34015
@NP	et al.	34015
@NP	1994	34023
@NP	stimulation of the calcium-dependent glutamate release	34037
@NP	stimulation	34037
@NP	the calcium-dependent glutamate release	34052
@NP	astrocytes	34097
@NP	prostaglandins -LRB- Bezzi et al. , 1998 -RRB-	34111
@NP	prostaglandins	34111
@NP	Bezzi	34127
@NP	et al. , 1998	34133
@NP	et al.	34133
@NP	1998	34141
@NP	contrast	34151
@NP	several in vitro studies	34161
@NP	several	34161
@NP	prostaglandins	34202
@NP	protective effects	34227
@NP	rat neurons following glutamate , nitric oxide , and hypoxic damage	34258
@NP	rat neurons	34258
@NP	glutamate , nitric oxide , and hypoxic damage	34280
@NP	glutamate	34280
@NP	nitric oxide	34291
@NP	hypoxic damage	34309
@NP	Akaike et al. , 1994 ; Otsuki et al. , 1994 ; Kikuchi et al. , 2002	34325
@NP	Akaike	34325
@NP	et al. , 1994 ; Otsuki et al. , 1994 ; Kikuchi et al. , 2002	34332
@NP	et al. , 1994	34332
@NP	et al.	34332
@NP	1994	34340
@NP	Otsuki et al. , 1994	34346
@NP	Otsuki	34346
@NP	et al. , 1994	34353
@NP	et al.	34353
@NP	1994	34361
@NP	Kikuchi et al. , 2002	34367
@NP	Kikuchi	34367
@NP	et al. , 2002	34375
@NP	et al.	34375
@NP	2002	34383
@NP	it	34396
@NP	a matter of controversy	34408
@NP	a matter	34408
@NP	controversy	34420
@NP	COX-2 and prostaglandins	34440
@NP	a beneficial or a detrimental effect	34470
@NP	the injured tissue	34510
@NP	The results of the present study	34530
@NP	The results	34530
@NP	the present study	34545
@NP	upregulation of COX-2 expression induced by OEC-transplants	34576
@NP	upregulation	34576
@NP	COX-2 expression induced by OEC-transplants	34592
@NP	COX-2 expression	34592
@NP	OEC-transplants	34620
@NP	a neuroprotective role	34642
@NP	the first days postlesion	34672
@NP	spinal cord injury	34705
@NP	the expression of VEGF and its receptors	34725
@NP	the expression	34725
@NP	VEGF and its receptors	34743
@NP	VEGF	34743
@NP	its receptors	34752
@NP	the lesioned area	34782
@NP	an in vitro model	34807
@NP	model	34819
@NP	cell cultures of meningeal fibroblasts and astrocytes	34830
@NP	cell cultures	34830
@NP	meningeal fibroblasts and astrocytes	34847
@NP	it	34885
@NP	VEGF	34908
@NP	astrocytes	34929
@NP	treatment	34946
@NP	PGF2alpha and PGE2 -LRB- Sköld et al. , 2000 -RRB-	34961
@NP	PGF2alpha and PGE2	34961
@NP	Sköld	34981
@NP	et al. , 2000	34987
@NP	et al.	34987
@NP	2000	34995
@NP	All these findings	35002
@NP	a relationship between COX - 2 , prostaglandins and VEGF	35030
@NP	a relationship between COX	35030
@NP	a relationship	35030
@NP	COX	35053
@NP	2 , prostaglandins and VEGF	35058
@NP	2	35058
@NP	prostaglandins	35061
@NP	VEGF	35080
@NP	spinal cord injuries	35091
@NP	VEGF	35113
@NP	endothelial cell proliferation , angiogenesis , vascular permeability	35127
@NP	Proescholdt	35196
@NP	et al. , 1999	35208
@NP	et al.	35208
@NP	1999	35216
@NP	Bartholdi et al. , 1997	35222
@NP	Bartholdi	35222
@NP	et al. , 1997	35232
@NP	et al.	35232
@NP	1997	35240
@NP	Salhia et al. , 2000	35246
@NP	Salhia	35246
@NP	et al. , 2000	35253
@NP	et al.	35253
@NP	2000	35261
@NP	Facchiano et al. , 2002	35267
@NP	Facchiano	35267
@NP	et al. , 2002	35277
@NP	et al.	35277
@NP	2002	35285
@NP	it	35296
@NP	the extent	35324
@NP	corticospinal axon retrograde degeneration -LRB- Facchiano et al. , 2002 -RRB-	35338
@NP	corticospinal axon retrograde degeneration	35338
@NP	Facchiano	35382
@NP	et al. , 2002	35392
@NP	et al.	35392
@NP	2002	35400
@NP	Casella et al. -LRB- 2002 -RRB-	35417
@NP	Casella et al.	35417
@NP	Casella	35417
@NP	et al.	35425
@NP	2002	35433
@NP	a vigorous growth of new blood vessels	35448
@NP	a vigorous growth	35448
@NP	new blood vessels	35469
@NP	between 4 and 7 days	35487
@NP	moderate spinal cord contusion	35514
@NP	7 days	35549
@NP	the newly formed vessels	35568
@NP	reactive astrocytes	35614
@NP	summary	35638
@NP	neoangiogenesis	35647
@NP	the upregulation of COX-2 , prostaglandins and VEGF	35679
@NP	the upregulation	35679
@NP	COX-2 , prostaglandins and VEGF	35699
@NP	spinal cord blood supply	35739
@NP	hypoxia and neuronal death	35773
@NP	hypoxia	35773
@NP	neuronal death	35785
@NP	formation of a substrate	35814
@NP	formation	35814
@NP	a substrate	35827
@NP	laminin	35847
@NP	the disrupted axons	35861
@NP	the neoformation of blood vessels	35924
@NP	the neoformation	35924
@NP	blood vessels	35944
@NP	spinal cord injury	35972
@NP	a potential repair strategy	35998
@NP	a natural bridge	36035
@NP	axonal regeneration	36075
@NP	nutritional support	36109
@NP	agreement with our results	36133
@NP	agreement	36133
@NP	our results	36148
@NP	slightly higher numbers of blood vessels	36161
@NP	slightly higher numbers	36161
@NP	blood vessels	36188
@NP	OEC	36224
@NP	DMEMinjected rats after spinal cord contusion	36237
@NP	DMEMinjected rats	36237
@NP	spinal cord contusion	36261
@NP	the spared spinal cord tissue	36288
@NP	43 % and 33 % in the same experimental groups	36328
@NP	43 % and 33 %	36328
@NP	the same experimental groups	36343
@NP	Takami	36375
@NP	et al. -LRB- 2002 -RRB-	36382
@NP	et al.	36382
@NP	2002	36390
@NP	Previous studies from our laboratory	36397
@NP	Previous studies	36397
@NP	our laboratory	36419
@NP	OECs	36446
@NP	the reactivity	36472
@NP	astrocytes	36490
@NP	their expression of GFAP and proteoglycan	36513
@NP	their expression	36513
@NP	GFAP and proteoglycan	36533
@NP	a spinal cord injury -LRB- Verdú et al. , 2001 , 2003 -RRB-	36561
@NP	a spinal cord injury	36561
@NP	Verdú	36583
@NP	et al. , 2001 , 2003	36589
@NP	et al.	36589
@NP	2001	36597
@NP	2003	36603
@NP	Preliminary studies	36610
@NP	larger numbers of LEC-positive round cells	36644
@NP	larger numbers	36644
@NP	LEC-positive round cells	36662
@NP	the spinal cord parenchyma at 7 dpo in OEC rats	36703
@NP	the spinal cord parenchyma	36703
@NP	7 dpo in OEC rats	36733
@NP	7 dpo	36733
@NP	OEC rats	36742
@NP	DMEM rats	36759
@NP	the reverse	36776
@NP	14 dpo -LRB- unpublished observations -RRB-	36800
@NP	14 dpo	36800
@NP	unpublished observations	36808
@NP	The restorative ability	36835
@NP	OEC transplants	36862
@NP	spinal cord parenchyma preservation via modulation of microglia	36891
@NP	spinal cord parenchyma preservation	36891
@NP	modulation of microglia	36931
@NP	modulation	36931
@NP	microglia	36945
@NP	macrophage reactivity	36956
@NP	further investigation	36984
@VP	Transplanted	109
@VP	were transplanted in adult rats after photochemical injury of the spinal cord	295
@VP	transplanted in adult rats after photochemical injury of the spinal cord	300
@VP	received either 180,000 OECs suspended in DMEM or DMEM alone	379
@VP	suspended in DMEM or DMEM alone	408
@VP	scored by the BBB-scale , pain sensibility , and motor and somatosensory	459
@VP	evoked potentials were evaluated during the first 14 days post-surgery	530
@VP	were evaluated during the first 14 days post-surgery	548
@VP	evaluated during the first 14 days post-surgery	553
@VP	were perfused	654
@VP	perfused	659
@VP	were stained for COX-2 , VEGF , GFAP and lectin	746
@VP	stained for COX-2 , VEGF , GFAP and lectin	751
@VP	was lower in OEC	1012
@VP	were significantly higher in OEC - than in DMEM-injected rats	1134
@VP	expressed COX-2 staining in OEC-transplanted rats	1228
@VP	was also significantly increased in OEC - with respect to DMEM-injected rats	1308
@VP	significantly increased in OEC - with respect to DMEM-injected rats	1317
@VP	observed after spinal cord injury -LRB- Schwab and Bartholdi , 1996 -RRB-	1819
@VP	may be neuroprotective rather than neurodestructive if well controlled	1935
@VP	be neuroprotective rather than neurodestructive if well controlled	1939
@VP	to be effective and need to be amplified	2029
@VP	be effective and need to be amplified	2032
@VP	be effective	2032
@VP	need to be amplified	2049
@VP	to be amplified	2054
@VP	be amplified	2057
@VP	amplified	2060
@VP	promotes axonal regrowth -LRB- Rapalino et al. , 1998 -RRB-	2208
@VP	produced by macrophages , but also by activated microglia and astrocytes	2287
@VP	may explain this effect -LRB- Rapalino et al. , 1998 -RRB-	2359
@VP	explain this effect -LRB- Rapalino et al. , 1998 -RRB-	2363
@VP	depending on the phase of recovery	2693
@VP	is predominantly required -LRB- Schwartz et al. , 1996 ; Schwartz , 2000 -RRB-	2762
@VP	required -LRB- Schwartz et al. , 1996 ; Schwartz , 2000 -RRB-	2779
@VP	induced neuronal death after spinal cord injury -LRB- Siesjo , 1992 -RRB-	3265
@VP	are induced after mechanical spinal cord injury	3433
@VP	induced after mechanical spinal cord injury	3437
@VP	promote functional	3941
@VP	implicated in this neuroprotective role	4092
@VP	are still unknown	4132
@VP	to amplify the immune and inflammatory responses after spinal cord injury	4224
@VP	amplify the immune and inflammatory responses after spinal cord injury	4227
@VP	upregulate the expression of COX-2 and VEGF	4337
@VP	were obtained from primary cultures of olfactory bulbs	4577
@VP	obtained from primary cultures of olfactory bulbs	4582
@VP	described by Gudiño-Cabrera and Nieto-Sampedro	4710
@VP	was stripped off with fine forceps	4997
@VP	stripped off with fine forceps	5001
@VP	was mechanically dissociated using a flame-constricted Pasteur pipette	5330
@VP	dissociated using a flame-constricted Pasteur pipette	5347
@VP	using a flame-constricted Pasteur pipette	5359
@VP	recovered by centrifugation at 900 rpm for 7 min	5627
@VP	resuspended in culture medium	5680
@VP	coated with poly-Llysine -LRB- 10 µg/mL , P-7890 , Sigma -RRB-	5753
@VP	incubated in 5 % CO2 at 37 °C	5809
@VP	was DMEM with 10 % FCS	5853
@VP	expanding OECs -LRB- Gudiño-Cabrera and Nieto-Sampedro , 2000 -RRB-	5945
@VP	reaching confluence -LRB- 12 -- 15 days in vitro -RRB-	6009
@VP	were detached by incubation with trypsin-EDTA -LRB- T - 3924 , Sigma -RRB-	6057
@VP	detached by incubation with trypsin-EDTA -LRB- T - 3924 , Sigma -RRB-	6062
@VP	was arrested by addition of medium	6136
@VP	arrested by addition of medium	6140
@VP	was recovered by centrifugation at 900 rpm for 7 min	6192
@VP	recovered by centrifugation at 900 rpm for 7 min	6196
@VP	pre-coated with goat anti-mouse IgG	6338
@VP	attached with mouse	6378
@VP	resuspended in freezing medium -LRB- C-6295 , Sigma -RRB-	6578
@VP	transferred to -20 °C for 10 min , then to a deep freezer at -80 °C	6644
@VP	washed two times by centrifugation -LRB- 900 rpm , 7 min -RRB- in DMEM	6770
@VP	resuspended in the same medium	6846
@VP	were transplanted within 2 h of thawing	6888
@VP	transplanted within 2 h of thawing	6893
@VP	had a flattened appearance	7089
@VP	were also identified in the cultures	7152
@VP	identified in the cultures	7162
@VP	were p75-positive	7312
@VP	stain was used for determining the viable cell number	7576
@VP	was used for determining the viable cell number	7582
@VP	used for determining the viable cell number	7586
@VP	determining the viable cell number	7595
@VP	Stained	7631
@VP	were counted with a haemocytometer	7659
@VP	counted with a haemocytometer	7664
@VP	was calculated	7731
@VP	calculated	7735
@VP	stain test was repeated three times	7763
@VP	was repeated three times	7774
@VP	repeated three times	7778
@VP	was about 97 -- 98 % from the total cells	7861
@VP	anesthetized with sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	8000
@VP	placed prone on a heating pad to maintain body temperature constant	8060
@VP	to maintain body temperature constant	8090
@VP	maintain body temperature constant	8093
@VP	was shaved and disinfected with povidone iodine	8153
@VP	shaved and disinfected with povidone iodine	8157
@VP	was made	8265
@VP	made	8269
@VP	was exposed by a dorsal laminectomy of T8 vertebra	8291
@VP	exposed by a dorsal laminectomy of T8 vertebra	8295
@VP	was carefully cut to facilitate penetration of solutions	8352
@VP	cut to facilitate penetration of solutions	8366
@VP	to facilitate penetration of solutions	8370
@VP	facilitate penetration of solutions	8373
@VP	was applied directly on the exposed spinal cord for 10 minutes	8450
@VP	applied directly on the exposed spinal cord for 10 minutes	8454
@VP	dye easily	8536
@VP	affecting preferentially the gray matter -LRB- Verdú et al. , 2003b -RRB-	8579
@VP	dye was removed by a double saline rinse	8660
@VP	was removed by a double saline rinse	8664
@VP	removed by a double saline rinse	8668
@VP	positioned 10 mm on top of the cord -LRB- Verdú et al. , 2003a , b -RRB-	8827
@VP	was connected to a halogen lamp equipped with a 100 -- W Xenophot halogen bulb	8904
@VP	connected to a halogen lamp equipped with a 100 -- W Xenophot halogen bulb	8908
@VP	equipped with a 100 -- W Xenophot halogen bulb	8936
@VP	To obtain reproducible light intensity	8981
@VP	obtain reproducible light intensity	8984
@VP	was measured by means of a digital lux tester	9063
@VP	measured by means of a digital lux tester	9067
@VP	was illuminated at a light intensity of 200 kLux during 2.5 min	9122
@VP	illuminated at a light intensity of 200 kLux during 2.5 min	9126
@VP	was bathed with saline solution	9295
@VP	bathed with saline solution	9299
@VP	described previously	9331
@VP	was carefully inserted from the dorsal surface 1 mm deep into the spinal cord	9848
@VP	inserted from the dorsal surface 1 mm deep into the spinal cord	9862
@VP	received a total of 180,000 OECs	9939
@VP	was closed	10260
@VP	closed	10264
@VP	were kept in a warm environment until full recovery	10287
@VP	kept in a warm environment until full recovery	10292
@VP	using the open-field walking scoring system	10490
@VP	measuring the locomotor ability during 5 min	10538
@VP	observed the hind-limb movements of the rat	10727
@VP	was the mean value of both examiners	10922
@VP	subjected to the inclined plane test -LRB- Rivlin and Tator , 1977 -RRB-	11071
@VP	could maintain a stable position for 5 sec on the inclined plane	11172
@VP	maintain a stable position for 5 sec on the inclined plane	11178
@VP	was recorded	11237
@VP	recorded	11241
@VP	using a plantar algesimeter -LRB- Hargreaves et al. , 1988 -RRB-	11316
@VP	was placed into a plastic box with an elevated glass floor	11379
@VP	placed into a plastic box with an elevated glass floor	11383
@VP	was focused directly onto the plantar surface of the hindpaw	11506
@VP	focused directly onto the plantar surface of the hindpaw	11510
@VP	coupled with infrared detectors directed to the plantar surface	11664
@VP	directed to the plantar surface	11696
@VP	was limited to 40 sec to avoid skin damage	11761
@VP	limited to 40 sec to avoid skin damage	11765
@VP	to avoid skin damage	11783
@VP	avoid skin damage	11786
@VP	was the mean of three trials separated by 5 min resting periods	11826
@VP	separated by 5 min resting periods	11855
@VP	resting periods	11874
@VP	evoked potentials	11947
@VP	to evaluate the integrity of spinal cord descending and ascending tracts	11979
@VP	evaluate the integrity of spinal cord descending and ascending tracts	11982
@VP	descending and ascending tracts	12020
@VP	circulating pump to maintain skin temperature above 32 °C	12204
@VP	to maintain skin temperature above 32 °C	12221
@VP	maintain skin temperature above 32 °C	12224
@VP	using monopolar needle electrodes from the tibialis anterior muscle	12307
@VP	overlying the sensorimotor cortex and the anode at the nose	12605
@VP	evoked potentials -LRB- SSEPs -RRB-	12834
@VP	inserted at the ankle	12998
@VP	Evoked responses were recorded using two needle electrodes	13021
@VP	were recorded using two needle electrodes	13038
@VP	recorded using two needle electrodes	13043
@VP	using two needle electrodes	13052
@VP	were recorded during 100 msec following each stimulus , and averaged	13186
@VP	were recorded during 100 msec following each stimulus	13186
@VP	recorded during 100 msec following each stimulus	13191
@VP	averaged	13245
@VP	amplified	13272
@VP	filtered	13283
@VP	to measure the amplitude	13350
@VP	measure the amplitude	13353
@VP	evoked potentials -LRB- García-Alías et al. , 2003 -RRB-	13398
@VP	To ensure reproducibility the recording and stimulating needles	13445
@VP	ensure reproducibility the recording and stimulating needles	13448
@VP	stimulating needles	13489
@VP	to secure the same placement on all animals guided by anatomical landmarks	13540
@VP	secure the same placement on all animals guided by anatomical landmarks	13543
@VP	guided by anatomical landmarks	13584
@VP	was removed and postfixed in the same solution for 24 h -LRB- lesion block -RRB-	13912
@VP	removed and postfixed in the same solution for 24 h -LRB- lesion block -RRB-	13916
@VP	were also removed and fixed as above	14062
@VP	removed and fixed as above	14072
@VP	were cryoprotected in PBS containing 30 % sucrose and stored at 4 °C	14162
@VP	were cryoprotected in PBS containing 30 % sucrose	14162
@VP	cryoprotected in PBS containing 30 % sucrose	14167
@VP	containing 30 % sucrose	14188
@VP	stored at 4 °C	14215
@VP	labeled avidin -LRB- 1:200 , Jackson Immunoresearch -RRB- overnight at 4 °C	15132
@VP	mounted on gelatin-coated slides	15240
@VP	dehydrated in ethanol	15274
@VP	mounted with DPX -LRB- Fluka -RRB-	15300
@VP	were incubated without primary antibody , and processed as described above	15366
@VP	incubated without primary antibody , and processed as described above	15371
@VP	incubated without primary antibody	15371
@VP	processed as described above	15411
@VP	described above	15424
@VP	equipped with epifluorescence using appropriate filters	15495
@VP	using appropriate filters	15525
@VP	labeled	15670
@VP	labeled	15705
@VP	attached to the microscope and analyzed using NIH Image software	15834
@VP	attached to the microscope	15834
@VP	analyzed using NIH Image software	15865
@VP	using NIH Image software	15874
@VP	stained for GFAP	15921
@VP	measuring the area of preserved cord parenchyma	15952
@VP	surrounding and delimiting the destroyed parenchyma	16069
@VP	surrounding	16069
@VP	delimiting the destroyed parenchyma	16085
@VP	made these measurements over the same images	16152
@VP	analyzed	16270
@VP	was the mean value of both subjects	16279
@VP	were studied -LRB- Verdú et al. , 2003a -RRB-	16371
@VP	studied -LRB- Verdú et al. , 2003a -RRB-	16376
@VP	labeled against COX-2 and VEGF	16428
@VP	described by Acarin et al. -LRB- 1997 -RRB-	16525
@VP	referred to as the `` reactivity grade , ''	16590
@VP	calculated as follows	16811
@VP	follows	16825
@VP	was obtained for COX-2 and for VEGF in each spinal cord block	16900
@VP	obtained for COX-2 and for VEGF in each spinal cord block	16904
@VP	were used for these measurements	17001
@VP	used for these measurements	17006
@VP	to reduce variability	17044
@VP	reduce variability	17047
@VP	corresponding to each marker and spinal block from lesioned and control animals	17080
@VP	were processed simultaneously	17160
@VP	processed simultaneously	17165
@VP	was the same for all the images	17225
@VP	counting the number of blood vessel profiles in the grey matter of ventral horns	17374
@VP	representing more than 97 % of the horn at x50	17476
@VP	counted	17602
@VP	blocks per animal were studied	17685
@VP	were studied	17703
@VP	studied	17708
@VP	was calculated from these counts	17768
@VP	calculated from these counts	17772
@VP	were performed in a `` blinded '' manner	17890
@VP	performed in a `` blinded '' manner	17895
@VP	using a code	17928
@VP	are shown as the mean ± SEM	17979
@VP	shown as the mean ± SEM	17983
@VP	were made by nonparametric Kruskal-Wallis and Mann-Whitney U-tests	18047
@VP	made by nonparametric Kruskal-Wallis and Mann-Whitney U-tests	18052
@VP	were considered significant if p < 0.05	18127
@VP	considered significant if p < 0.05	18132
@VP	were analyzed using lineal regression	18221
@VP	analyzed using lineal regression	18226
@VP	using lineal regression	18235
@VP	adhered to the recommendations of the European Union and the U.S.	18288
@VP	Department of Health for the care and use of laboratory animals	18354
@VP	were approved by the Ethics Committee of our institution	18422
@VP	approved by the Ethics Committee of our institution	18427
@VP	TABLE 1	18489
@VP	BLOCKS AT 3 , 7 , AND 14 DAYS POSTOPERATION -LRB- DPO -RRB- TABLE 2	18590
@VP	FIG. 1	18730
@VP	evaluated by the BBB-score -LRB- A -RRB- , and the time to withdrawal	18789
@VP	filled columns	18944
@VP	are the mean , and error bars the SEM	19022
@VP	left panels	19129
@VP	filled column	19799
@VP	are the mean , and error bars the SEM	19895
@VP	immunostained for COX-2 -LRB- A -- F -RRB- and VEGF -LRB- G -- L -RRB-	19963
@VP	are representative of the mean changes in each group	20251
@VP	= 1000 µm -LRB- A -- L -RRB- , 50 µm -LRB- M , N -RRB-	20309
@VP	filled column	20494
@VP	are the mean and error bars the SEM	20613
@VP	indicates colocalization	20878
@VP	= 50 µm	20908
@VP	lesioning the spinal cord	20944
@VP	showed normal locomotor behavior -LRB- score 21 -RRB-	20983
@VP	decreased to mean values of 10 in group DMEM and 16 in group OEC	21052
@VP	to mean values of 10 in group DMEM and 16 in group OEC	21062
@VP	mean values of 10 in group DMEM and 16 in group OEC	21065
@VP	had significantly higher scores than group DMEM at all postlesion times	21280
@VP	were about 48 °	21425
@VP	decreased to 37 °	21474
@VP	to reach mean values of 41 ° and 48 ° in DMEM and OEC groups at 14 dpo	21550
@VP	reach mean values of 41 ° and 48 ° in DMEM and OEC groups at 14 dpo	21553
@VP	was significantly higher in OEC than in DMEM animals -LRB- p < 0.05 -RRB-	21674
@VP	evaluated by plantar algesimetry	21772
@VP	had a latency of about 9 sec before lesion	21805
@VP	increased at 7 dpo to 22 and 14 sec in DMEM and OEC groups , respectively	21921
@VP	decreased in group DMEM to 18 seconds , but did not change in group OEC	22000
@VP	decreased in group DMEM to 18 seconds	22000
@VP	did not change in group OEC	22043
@VP	change in group OEC	22051
@VP	recorded prior to operation	22209
@VP	showed a single wave with a mean latency of about 6 msec	22237
@VP	mean amplitude of about 15 mV in both groups -LRB- Fig. 2 -RRB-	22298
@VP	were observed during follow-up	22407
@VP	observed during follow-up	22412
@VP	decreased markedly in both groups by 3 dpo	22457
@VP	named as N1 , N2 , and N3 waves	22785
@VP	showed a cavity affecting the dorsal funiculus up to the central canal	23156
@VP	affecting the dorsal	23172
@VP	funiculus up to the central canal	23193
@VP	Destroyed parenchyma partially involving the lateral funiculi	23228
@VP	partially involving the lateral funiculi	23249
@VP	was seen at 14 dpo -LRB- Fig. 4 -RRB-	23290
@VP	seen at 14 dpo -LRB- Fig. 4 -RRB-	23294
@VP	had spread to dorsolateral areas -LRB- Fig. 4 -RRB-	23468
@VP	spread to dorsolateral areas -LRB- Fig. 4 -RRB-	23472
@VP	showed destroyed parenchyma in the dorsal funiculus	23607
@VP	destroyed parenchyma in the dorsal funiculus	23614
@VP	studied	23784
@VP	evaluated -LRB- Table 1 -RRB-	23907
@VP	to control rats	24033
@VP	control rats	24036
@VP	surrounding the cavity -LRB- Fig. 4A , B -RRB-	24173
@VP	filling the cavity -LRB- Fig. 4E -RRB-	24525
@VP	filled the cavity	24619
@VP	was about 4 and 8 in DMEM and OEC groups , respectively	24759
@VP	decreased progressively in both groups to about	24820
@VP	decreased to about 3 at 7 dpo and 2 at 14 dpo in both groups	25148
@VP	to about 3 at 7 dpo and 2 at 14 dpo in both groups	25158
@VP	about 3 at 7 dpo and 2 at 14 dpo in both groups	25161
@VP	averaged 6 and 5 in DMEM and OEC groups , respectively , at 3 dpo	25267
@VP	decreased to 2 at 14 dpo , in group OEC	25381
@VP	increased to 7 at 7 dpo , and then decreased	25423
@VP	increased to 7 at 7 dpo	25423
@VP	decreased	25457
@VP	were found between DMEM and OEC groups at 7 dpo -LRB- Fig. 5 -RRB-	25492
@VP	found between DMEM and OEC groups at 7 dpo -LRB- Fig. 5 -RRB-	25497
@VP	were positive to COX-2 and GFAP	25698
@VP	overlapped -LRB- Fig. 6C , D -RRB-	25810
@VP	was seen in GFAP-positive cells	26154
@VP	seen in GFAP-positive cells	26158
@VP	filled and surrounded the cavity	26222
@VP	filled	26222
@VP	surrounded the cavity	26233
@VP	was only detected in LEC-positive cells in the cavity	26311
@VP	detected in LEC-positive cells in the cavity	26320
@VP	was observed in spinal cord sections from proximal and distal blocks	26392
@VP	observed in spinal cord sections from proximal and distal blocks	26396
@VP	decreased in group DMEM -LRB- Fig. 4H -RRB-	26810
@VP	showed higher VEGF staining than the white matter	26965
@VP	was similar in both groups -LRB- Fig. 4I , L -RRB-	27041
@VP	decreased progressively with time postinjury	27161
@VP	taken from the distal block	27350
@VP	significantly higher in group OEC only at 7 dpo with respect	27383
@VP	was 515 ± 21 blood vessels / mm2	27601
@VP	was 378 ± 17 in group DMEM and 369 ± 9 blood vessels/mm2 in group OEC at 3 dpo	27671
@VP	averaged 512 ± 13 blood vessels/mm2	28155
@VP	was 517 ± 4 blood vessels/mm2	28590
@VP	seen at 3 dpo	29083
@VP	was significantly correlated with the VEGF reactivity grade at 7 dpo	29097
@VP	correlated with the VEGF reactivity grade at 7 dpo	29115
@VP	significantly correlated with the density of blood vessel profiles at 14 dpo	29207
@VP	increased by OEC transplantation -LRB- Verdú et al. , 2003a -RRB-	29898
@VP	received an injection of medium	29983
@VP	showed better locomotor function	30038
@VP	descending and ascending spinal pathways	30341
@VP	affected	30812
@VP	observed within the first two weeks after injury in the present study	30849
@VP	may be attributable to the reduction of edema	30919
@VP	be attributable to the reduction of edema	30923
@VP	had a better neurological and electrophysiological recovery	31002
@VP	had smaller cord tissue loss than DMEM-injected rats	31066
@VP	affected the spinal dorsal columns in animals of the OEC group	31153
@VP	had spread to the lateral funiculi in the DMEM-injected rats	31221
@VP	spread to the lateral funiculi in the DMEM-injected rats	31225
@VP	affecting also the ventral and lateral funiculi	31562
@VP	increased about 30 % in OEC-transplanted rats with respect to unlesioned rats	31787
@VP	transplanted into the lesioned cord	32245
@VP	are able to modulate these responses	32281
@VP	to modulate these responses	32290
@VP	modulate these responses	32293
@VP	linederived neurotrophic factor	32478
@VP	display Schwann-like properties	32729
@VP	express VEGF and PACAP	32767
@VP	are able to express all these molecules in vivo after transplantation	32827
@VP	to express all these molecules in vivo after transplantation	32836
@VP	express all these molecules in vivo after transplantation	32839
@VP	reported in the present study	32910
@VP	improve functional recovery	32990
@VP	increased in the lesion site	33473
@VP	remained at high levels during the first 14 days postinjury	33507
@VP	cultured rat neurons following glutamate , nitric oxide , and hypoxic damage	34249
@VP	have a beneficial or a detrimental effect on the injured tissue	34465
@VP	induced by OEC-transplants	34609
@VP	plays a neuroprotective role during the first days postlesion	34636
@VP	is increased in the lesioned area	34766
@VP	increased in the lesioned area	34769
@VP	were associated with reactive astrocytes	35593
@VP	associated with reactive astrocytes	35598
@VP	associated with the upregulation of COX-2 , prostaglandins and VEGF	35663
@VP	enhances spinal cord blood supply	35730
@VP	reduces hypoxia and neuronal death	35765
@VP	are able to grow	35881
@VP	to grow	35890
@VP	grow	35893
@VP	Preserving	35899
@VP	promoting the neoformation of blood vessels quickly after spinal cord injury	35914
@VP	is provided to support axonal regeneration and to supply nutritional support	36052
@VP	provided to support axonal regeneration and to supply nutritional support	36055
@VP	to support axonal regeneration and to supply nutritional support	36064
@VP	to support axonal regeneration	36064
@VP	support axonal regeneration	36067
@VP	to supply nutritional support	36099
@VP	supply nutritional support	36102
@VP	were also observed in OEC	36202
@VP	observed in OEC	36212
@VP	was about 43 % and 33 % in the same experimental groups by Takami	36318
@VP	was seen at 14 dpo -LRB- unpublished observations -RRB-	36788
@VP	seen at 14 dpo -LRB- unpublished observations -RRB-	36792
@VP	promoting spinal cord parenchyma preservation via modulation of microglia	36881
@VP	needs further investigation	36978
